JP6199443B2 - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP6199443B2 JP6199443B2 JP2016114582A JP2016114582A JP6199443B2 JP 6199443 B2 JP6199443 B2 JP 6199443B2 JP 2016114582 A JP2016114582 A JP 2016114582A JP 2016114582 A JP2016114582 A JP 2016114582A JP 6199443 B2 JP6199443 B2 JP 6199443B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- carbon atoms
- external preparation
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 60
- 230000000699 topical effect Effects 0.000 title description 2
- 239000000178 monomer Substances 0.000 claims description 89
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- 229920001577 copolymer Polymers 0.000 claims description 59
- 125000004432 carbon atom Chemical group C* 0.000 claims description 54
- 230000002209 hydrophobic effect Effects 0.000 claims description 51
- 125000002252 acyl group Chemical group 0.000 claims description 27
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 20
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 12
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 8
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 8
- 125000001931 aliphatic group Chemical group 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000004386 Erythritol Substances 0.000 claims description 6
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 claims description 6
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 6
- 235000019414 erythritol Nutrition 0.000 claims description 6
- 229940009714 erythritol Drugs 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 5
- 229940105990 diglycerin Drugs 0.000 claims description 5
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 5
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 5
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- UNXHWFMMPAWVPI-IMJSIDKUSA-N L-threitol Chemical compound OC[C@H](O)[C@@H](O)CO UNXHWFMMPAWVPI-IMJSIDKUSA-N 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 229940059574 pentaerithrityl Drugs 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- -1 polyethylene structure Polymers 0.000 description 143
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 56
- 238000004519 manufacturing process Methods 0.000 description 56
- 239000000243 solution Substances 0.000 description 55
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 54
- 235000019441 ethanol Nutrition 0.000 description 47
- 238000006243 chemical reaction Methods 0.000 description 44
- 238000003756 stirring Methods 0.000 description 37
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 32
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 28
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 28
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000543 intermediate Substances 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 230000003020 moisturizing effect Effects 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000002202 Polyethylene glycol Substances 0.000 description 14
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 14
- 229920001223 polyethylene glycol Polymers 0.000 description 14
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 229910001873 dinitrogen Inorganic materials 0.000 description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 12
- 239000006210 lotion Substances 0.000 description 11
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 229960005150 glycerol Drugs 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229920000058 polyacrylate Polymers 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000005292 vacuum distillation Methods 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- LFDKQJVNMJFNGG-UHFFFAOYSA-N 16-methylheptadecanoyl chloride Chemical compound CC(C)CCCCCCCCCCCCCCC(Cl)=O LFDKQJVNMJFNGG-UHFFFAOYSA-N 0.000 description 4
- BWUWLYUWMSCEMW-UHFFFAOYSA-N 19-methylicosanoyl chloride Chemical compound CC(C)CCCCCCCCCCCCCCCCCC(Cl)=O BWUWLYUWMSCEMW-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000003729 cation exchange resin Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920001451 polypropylene glycol Polymers 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 4
- SYENVBKSVVOOPS-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)butyl prop-2-enoate Chemical compound CCC(CO)(CO)COC(=O)C=C SYENVBKSVVOOPS-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000002649 leather substitute Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- BEWDYNRVCARDOP-UHFFFAOYSA-N 1-(chloromethyl)-4-(trifluoromethylsulfanyl)benzene Chemical compound FC(F)(F)SC1=CC=C(CCl)C=C1 BEWDYNRVCARDOP-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- BDGYZTCVQAZQFG-UHFFFAOYSA-N 19-methyleicosanoic acid Natural products CC(C)CCCCCCCCCCCCCCCCCC(O)=O BDGYZTCVQAZQFG-UHFFFAOYSA-N 0.000 description 2
- KICJYSRARHIXHM-UHFFFAOYSA-N 2,2-dimethyloctanoyl chloride Chemical compound CCCCCCC(C)(C)C(Cl)=O KICJYSRARHIXHM-UHFFFAOYSA-N 0.000 description 2
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 2
- TXHZNLCKXHJYNX-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)C(C)=C TXHZNLCKXHJYNX-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- YDQPKIAPLZBUKN-UHFFFAOYSA-N C(CCC)C(C(=O)Cl)(CCCCCC)CC Chemical compound C(CCC)C(C(=O)Cl)(CCCCCC)CC YDQPKIAPLZBUKN-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- ZCZFEIZSYJAXKS-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] prop-2-enoate Chemical compound OCC(CO)(CO)COC(=O)C=C ZCZFEIZSYJAXKS-UHFFFAOYSA-N 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- ZEIWWVGGEOHESL-UHFFFAOYSA-N methanol;titanium Chemical compound [Ti].OC.OC.OC.OC ZEIWWVGGEOHESL-UHFFFAOYSA-N 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 2
- 108700024047 pangamic acid Proteins 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- DOKHEARVIDLSFF-UHFFFAOYSA-N prop-1-en-1-ol Chemical group CC=CO DOKHEARVIDLSFF-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- FPJHWYCPAOPVIV-VOZMEZHOSA-N (2R,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-methoxy-3-sulfooxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CO[C@@H]1O[C@H](CO)[C@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@H]([C@@H](OC)[C@H](O)[C@H]2O)C(O)=O)[C@H]1NC(C)=O FPJHWYCPAOPVIV-VOZMEZHOSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HGOUNPXIJSDIKV-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)butyl 2-methylprop-2-enoate Chemical compound CCC(CO)(CO)COC(=O)C(C)=C HGOUNPXIJSDIKV-UHFFFAOYSA-N 0.000 description 1
- KHOUKKVJOPQVJM-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;prop-2-enoic acid Chemical compound OC(=O)C=C.OCC(CO)(CO)CO KHOUKKVJOPQVJM-UHFFFAOYSA-N 0.000 description 1
- IKNDGHRNXGEHTO-UHFFFAOYSA-N 2,2-dimethyloctanoic acid Chemical compound CCCCCCC(C)(C)C(O)=O IKNDGHRNXGEHTO-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- XMSSROAKQQJGIM-UHFFFAOYSA-N 2-(hydroxymethyl)-2-methylpropane-1,3-diol;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.OCC(C)(CO)CO XMSSROAKQQJGIM-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical group CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NTYGYRIDBOPKPI-UHFFFAOYSA-N 2-butyl-2-ethyloctanoic acid Chemical compound CCCCCCC(CC)(C(O)=O)CCCC NTYGYRIDBOPKPI-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- YMZGOBSAZNMINM-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCC(CO)(CO)CO.CCC(CO)(CO)CO YMZGOBSAZNMINM-UHFFFAOYSA-N 0.000 description 1
- WFSGQBNCVASPMW-UHFFFAOYSA-N 2-ethylhexanoyl chloride Chemical compound CCCCC(CC)C(Cl)=O WFSGQBNCVASPMW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
- KLPCZNSIPDGAJJ-UHFFFAOYSA-N 2-methoxy-3,3-dimethyl-1-phenylbutan-1-one Chemical compound COC(C(C)(C)C)C(=O)C1=CC=CC=C1 KLPCZNSIPDGAJJ-UHFFFAOYSA-N 0.000 description 1
- RKOOOVKGLHCLTP-UHFFFAOYSA-N 2-methylprop-2-enoic acid;propane-1,2,3-triol Chemical compound CC(=C)C(O)=O.OCC(O)CO RKOOOVKGLHCLTP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- GEKPNPPFAYJZRD-UHFFFAOYSA-N 3,5,5-trimethylhexanoyl chloride Chemical compound ClC(=O)CC(C)CC(C)(C)C GEKPNPPFAYJZRD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- PNGXUJXDFJQYAF-UHFFFAOYSA-L C(CC(O)(C(=O)[O-])CC(=O)O)(=O)O.[K+].C(CC(O)(C(=O)O)CC(=O)O)(=O)[O-].[K+] Chemical compound C(CC(O)(C(=O)[O-])CC(=O)O)(=O)O.[K+].C(CC(O)(C(=O)O)CC(=O)O)(=O)[O-].[K+] PNGXUJXDFJQYAF-UHFFFAOYSA-L 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- APZPSKFMSWZPKL-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(CO)(CO)CO APZPSKFMSWZPKL-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- MYSWGNHLJGOCPT-UHFFFAOYSA-N methyl prop-2-enoate;prop-2-enoic acid Chemical compound OC(=O)C=C.COC(=O)C=C MYSWGNHLJGOCPT-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- PQRHBEQNPCVBSM-UHFFFAOYSA-M potassium;2-carboxybenzoate;hydrochloride Chemical compound Cl.[K+].OC(=O)C1=CC=CC=C1C([O-])=O PQRHBEQNPCVBSM-UHFFFAOYSA-M 0.000 description 1
- KVMLCRQYXDYXDX-UHFFFAOYSA-M potassium;chloride;hydrochloride Chemical compound Cl.[Cl-].[K+] KVMLCRQYXDYXDX-UHFFFAOYSA-M 0.000 description 1
- AFDCXHSYKIVOOQ-UHFFFAOYSA-K potassium;disodium;phosphate Chemical compound [Na+].[Na+].[K+].[O-]P([O-])([O-])=O AFDCXHSYKIVOOQ-UHFFFAOYSA-K 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- NARVIWMVBMUEOG-UHFFFAOYSA-N prop-1-en-2-ol Chemical group CC(O)=C NARVIWMVBMUEOG-UHFFFAOYSA-N 0.000 description 1
- ARJOQCYCJMAIFR-UHFFFAOYSA-N prop-2-enoyl prop-2-enoate Chemical compound C=CC(=O)OC(=O)C=C ARJOQCYCJMAIFR-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- GHJOIQFPDMIKHT-UHFFFAOYSA-N propane-1,2,3-triol;prop-2-enoic acid Chemical compound OC(=O)C=C.OCC(O)CO GHJOIQFPDMIKHT-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical group CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、皮膚外用剤、更に詳細には、保湿効果に優れ、使用感良好な皮膚外用剤に関する。 The present invention relates to an external preparation for skin, and more particularly, to an external preparation for skin having an excellent moisturizing effect and good usability.
皮膚外用剤、特にスキンケア化粧料に求められる重要な機能として、肌の水分量を維持すること、すなわち、保湿効果がある。従来、皮膚外用剤に保湿効果を付与すべく、種々の保湿剤を皮膚外用剤に含有させる試みがなされてきた。 An important function required for external preparations for skin, particularly skin care cosmetics, is to maintain the moisture content of the skin, that is, a moisturizing effect. Conventionally, attempts have been made to include various moisturizing agents in the skin external preparation in order to impart a moisturizing effect to the skin external preparation.
その中でも有力なものとして、種々のアクリル系ポリマーが挙げられる。具体的には、側鎖にホスホリルコリン構造を有するアクリル系ポリマー(例えば、特許文献1、特許文献2及び特許文献3参照)、側鎖に糖構造を有するアクリル系ポリマー(例えば、特許文献4参照)、側鎖にアミノ酸構造を有するアクリル系ポリマー(例えば、特許文献5参照)、側鎖にポリエチレン構造を有するアクリル系ポリマー(例えば、特許文献6参照)等が挙げられる。しかしながら、これらの技術に於いては、保湿効果は向上するものの、ポリマーの特性に由来して、使用時に、べたつきを感じたり、きしみ(塗布時の抵抗、なめらかさの欠如)を感じたりするという、課題が生じる場合があった。 Among them, various acrylic polymers can be cited as leading ones. Specifically, an acrylic polymer having a phosphorylcholine structure in the side chain (see, for example, Patent Document 1, Patent Document 2, and Patent Document 3), and an acrylic polymer having a sugar structure in the side chain (see, for example, Patent Document 4) An acrylic polymer having an amino acid structure in the side chain (for example, see Patent Document 5), an acrylic polymer having a polyethylene structure in the side chain (for example, see Patent Document 6), and the like. However, with these technologies, the moisturizing effect is improved, but due to the characteristics of the polymer, it feels sticky during use or feels squeaky (resistance during application, lack of smoothness). There was a case where a problem arises.
これらの課題を解決すべく、フルオロアルキル基を有するアクリル系ポリマーを皮膚外用剤に含有させる試み(例えば、特許文献7、特許文献8及び特許文献9参照)がなされてきた。これらの技術に於いては、高い保湿効果とべたつきのなさは両立されたが、きしみ解消に関しては、ほとんど効果がなかった。 In order to solve these problems, attempts have been made to include an acrylic polymer having a fluoroalkyl group in an external preparation for skin (see, for example, Patent Document 7, Patent Document 8, and Patent Document 9). In these techniques, a high moisturizing effect and non-stickiness were compatible, but there was almost no effect on removing squeaks.
したがって、皮膚外用剤に高い保湿効果と、べたつき、きしみのない優れた使用感を与えることができる素材の開発が望まれていた。 Therefore, it has been desired to develop a material capable of giving a high moisturizing effect to the skin external preparation and an excellent feeling of use without stickiness and creaking.
一方、一つの(メタ)アクロイル基及び複数の、特定の分岐構造のアシル基を有するアクリルエステル系モノマーと、特定の親水性構造のアクリル系モノマーを重合して得られるコポリマーが皮膚外用剤に高い保湿効果とべたつき及びきしみのない優れた使用感を与えることは知られていなかった。 On the other hand, a copolymer obtained by polymerizing one (meth) acryloyl group and a plurality of acrylic ester monomers having a specific branched structure acyl group and a specific hydrophilic structure acrylic monomer is high in a topical skin preparation. It has not been known to give a moisturizing effect and an excellent feeling of use without stickiness and squeak.
本発明の目的は、優れた保湿効果と、べたつき及びきしみのない優れた使用感を有する皮膚外用剤を提供することにある。 The objective of this invention is providing the skin external preparation which has the outstanding moisturizing effect and the outstanding usability without stickiness and a squeak.
このような状況を鑑み、本発明者等は、優れた保湿効果と、べたつき及びきしみのない優れた使用感を有する皮膚外用剤を求めて鋭意研究した結果、一つの(メタ)アクロイル基及び複数の、特定の分岐構造のアシル基を有するアクリルエステル系モノマーと、特定の親水性構造のアクリル系モノマーを重合して得られるコポリマーが皮膚外用剤に高い保湿効果とべたつき及びきしみのない優れた使用感を与えることを見出し、本発明に至った。すなわち、本発明は以下の通りである。
(1)下記一般式(I)または(II)で表される疎水性モノマーから誘導される一種または二種以上の構成単位と下記A群からなる親水性モノマーから誘導される一種または二種以上の構成単位を必須構成単位として有し、他の構成単位を有していてもよいコポリマーを含有することを特徴とする皮膚外用剤。
一般式(I)
(一般式(I)中R1は水素原子または炭素数1〜3のアルキル基を表し、R2,R3は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数6〜22のアシル基を表す。Pは三価のアルコールからOH基が脱離した基を表す。)
一般式(II)
(一般式(II)中R4は水素原子または炭素数1〜3のアルキル基を表し、R5,R6,R7は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数6〜22のアシル基を表す。Qは四価のアルコールからOH基が脱離した基を表す。)
A群:重合性カルボン酸、下記一般式(III)で表される親水性モノマー
一般式(III)
(一般式(III)中R8は水素原子または炭素数1〜3のアルキル基を表し、R9は水酸基を有していてもよい炭素数2〜4のアルキレン基を表し、R10は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。nは6〜40の整数を表す。)
(2)一般式(I)で表される疎水性モノマーが下記一般式(IV)で表される疎水性モノマーであり、かつ、一般式(II)で表される疎水性モノマーが下記一般式(V)で表される疎水性モノマーであることを特徴とする(1)記載の皮膚外用剤。
一般式(IV)
(一般式(IV)中R11は水素原子または炭素数1〜3のアルキル基を表し、R12,R13は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数10〜22のアシル基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜9のアシル基を表す。Sは三価のアルコールからOH基が脱離した基を表す。)
一般式(V)
(一般式(V)中R14は水素原子または炭素数1〜3のアルキル基を表し、R15,R16,R17は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数10〜22のアシル基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜9のアシル基を表す。Tは四価のアルコールからOH基が脱離した基を表す。)
(3)一般式(III)で表される親水性モノマーが、下記一般式(VI)で表される親水性モノマーであることを特徴とする(1)または(2)記載の皮膚外用剤。
一般式(VI)
(一般式(VI)中R18は水素原子または炭素数1〜3のアルキル基を表し、R19は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。mは6〜40の整数を表す。)
(4)重合性カルボン酸がアクリル酸及び/またはメタクリル酸であることを特徴とする(1)〜(3)いずれかに記載の皮膚外用剤。
(5)三価アルコールがグリセリン、トリメチロールプロパン、トリメチロールエタンからなる群から選択されることを特徴とする(1)〜(4)いずれかに記載の皮膚外用剤。
(6)四価のアルコールがジグリセリン、ペンタエリスリトール、エリスリトール、D−トレイトール、L−トレイトールからなる群から選択される四価のアルコールであることを特徴とする(1)〜(4)いずれかに記載の皮膚外用剤。
(7)化粧料であることを特徴とする(1)〜(6)の何れかに記載の皮膚外用剤。
In view of such a situation, the present inventors have intensively studied for an external preparation for skin having an excellent moisturizing effect and an excellent feeling of use without stickiness and creaking. As a result, one (meth) acryloyl group and plural The use of an acrylic ester monomer having an acyl group having a specific branched structure and a copolymer obtained by polymerizing an acrylic monomer having a specific hydrophilic structure has a high moisturizing effect and excellent use without stickiness and creaking. It found out that it gave a feeling and came to this invention. That is, the present invention is as follows.
(1) One or two or more structural units derived from a hydrophobic monomer represented by the following general formula (I) or (II) and one or more structural units derived from a hydrophilic monomer consisting of the following group A The skin external preparation characterized by containing the copolymer which may have other structural units as an essential structural unit.
Formula (I)
(In the general formula (I), R 1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 2 and R 3 may be the same or different, have no ring structure and have a branched carbon number. Represents an acyl group of 6 to 22. P represents a group in which an OH group is eliminated from a trivalent alcohol.
Formula (II)
(In the general formula (II), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 5 , R 6 and R 7 may be the same or different and do not contain a ring structure and have a branch. Represents an acyl group having 6 to 22 carbon atoms, Q represents a group in which an OH group is eliminated from a tetravalent alcohol.
Group A: polymerizable carboxylic acid, hydrophilic monomer represented by the following general formula (III) general formula (III)
(In the general formula (III), R 8 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 9 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 10 represents hydrogen. An atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, an aliphatic hydrocarbon group having 1 to 14 carbon atoms, or an acyl group having 1 to 12 carbon atoms, and n represents an integer of 6 to 40.)
(2) The hydrophobic monomer represented by the general formula (I) is a hydrophobic monomer represented by the following general formula (IV), and the hydrophobic monomer represented by the general formula (II) is represented by the following general formula The external preparation for skin according to (1), which is a hydrophobic monomer represented by (V).
Formula (IV)
(In the general formula (IV), R 11 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 12 and R 13 may be the same or different, have no ring structure, and have a branched carbon number. It represents an acyl group having 10 to 22 or a C 6-9 acyl group having two or more branches that does not contain a ring structure, and S represents a group in which an OH group is eliminated from a trivalent alcohol. )
General formula (V)
(In the general formula (V), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 , R 16 , and R 17 may be the same or different and do not include a ring structure and have a branch. Represents an acyl group having 10 to 22 carbon atoms, or an acyl group having 6 to 9 carbon atoms having two or more branches that does not contain a ring structure, and T represents a group in which an OH group is eliminated from a tetravalent alcohol. Represents.)
(3) The skin external preparation according to (1) or (2), wherein the hydrophilic monomer represented by the general formula (III) is a hydrophilic monomer represented by the following general formula (VI).
Formula (VI)
(In the general formula (VI), R 18 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 19 represents a hydrogen atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, or an aliphatic group having 1 to 14 carbon atoms. A hydrocarbon group or a C1-C12 acyl group is represented.m represents an integer of 6-40.)
(4) The external preparation for skin according to any one of (1) to (3), wherein the polymerizable carboxylic acid is acrylic acid and / or methacrylic acid.
(5) The external preparation for skin according to any one of (1) to (4), wherein the trihydric alcohol is selected from the group consisting of glycerin, trimethylolpropane, and trimethylolethane.
(6) The tetravalent alcohol is a tetravalent alcohol selected from the group consisting of diglycerin, pentaerythritol, erythritol, D-threitol, and L-threitol (1) to (4) The external preparation for skin according to any one of the above.
(7) The external preparation for skin according to any one of (1) to (6), which is a cosmetic.
本発明によれば、優れた保湿効果と、べたつき及びきしみのない優れた使用感を有する皮膚外用剤が提供される。 ADVANTAGE OF THE INVENTION According to this invention, the skin external preparation which has the outstanding moisturizing effect and the outstanding usability without stickiness and a squeak is provided.
以下、本発明を詳細に説明する。
<1>本発明の皮膚外用剤の必須成分であるコポリマーを構成する疎水性モノマーから誘導される構成単位
本発明の皮膚外用剤の必須成分であるコポリマー(以下、単に本発明のコポリマーと呼ぶ場合がある)は下記一般式(I)又は一般式(II)で表される疎水性モノマーから誘導される構成単位(以下、単に、「構成単位I」または「構成単位II」と呼ぶこともある)の一種または二種以上を必須構成単位として含有する。
一般式(I)
(一般式(I)中R1は水素原子または炭素数1〜3のアルキル基を表し、R2,R3は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数6〜22のアシル基を表す。Pは三価のアルコールからOH基が脱離した基を表す。)
一般式(II)
(一般式(II)中R4は水素原子または炭素数1〜3のアルキル基を表し、R5,R6,R7は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数6〜22のアシル基を表す。Qは四価のアルコールからOH基が脱離した基を表す。)
Hereinafter, the present invention will be described in detail.
<1> A structural unit derived from a hydrophobic monomer constituting a copolymer that is an essential component of the external preparation for skin of the present invention A copolymer that is an essential component of the external preparation for skin of the present invention (hereinafter simply referred to as the copolymer of the present invention) Is a structural unit derived from a hydrophobic monomer represented by the following general formula (I) or general formula (II) (hereinafter sometimes simply referred to as “structural unit I” or “structural unit II”) 1) or 2 or more types thereof as essential constituent units.
Formula (I)
(In the general formula (I), R 1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 2 and R 3 may be the same or different, have no ring structure and have a branched carbon number. Represents an acyl group of 6 to 22. P represents a group in which an OH group is eliminated from a trivalent alcohol.
Formula (II)
(In the general formula (II), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 5 , R 6 and R 7 may be the same or different and do not contain a ring structure and have a branch. Represents an acyl group having 6 to 22 carbon atoms, Q represents a group in which an OH group is eliminated from a tetravalent alcohol.
ここで、R1,R4で表されるアルキル基としては、メチル基、エチル基、プロピル基、イソプロピル基、シクロプロピル基等が例示できる。本発明において、R1は水素原子又はメチル基であることが好ましい。 Here, examples of the alkyl group represented by R 1 and R 4 include a methyl group, an ethyl group, a propyl group, an isopropyl group, and a cyclopropyl group. In the present invention, R1 is preferably a hydrogen atom or a methyl group.
また、R2,R3,R5,R6,R7で表される環構造を含まない、分岐を有する炭素数6〜22のアシル基としては、2−メチルペンタノイル基、3−メチルペンタノイル基、4−メチルペンタノイル基、2−エチルブタノイル基、2−エチルブタノイル基、2,2−ジメチルブタノイル基、3,3−ジメチルブタノイル基、2−メチルヘキサノイル基、4−メチルヘキサノイル基、5−メチルヘキサノイル基、2,2−ジメチルペンタノイル基、4,4−ジメチルペンタノイル基、2−メチルヘプタノイル基、2−エチルヘキシル基、2−プロピルペンタノイル基、2,2−ジメチルヘキサノイル基、2,2,3−トリメチルペンタノイル基、2−メチルオクタノイル基、3,3,5−トリメチルヘキサノイル基、2−メチルノナノイル基、4−メチルノナノイル基、8−メチルノナノイル基、4−エチルオクタノイル基、2−エチルオクタノイル基、2−ブチルヘキサノイル基、2−tert−ブチルヘキサノイル基、2,2−ジエチルヘキサノイル基、2,2−ジメチルオクタノイル基、3,7−ジメチルオクタノイル基、ネオデカノイル基、7−メチルデカノイル基)、2−メチル−2−エチルオクタノイル基、2−メチルウンデカノイル基、10−メチルウンデカノイル基、2,2ジメチルデカノイル基、2−エチルデカノイル基、2−ブチルオクタノイル基、ジエチルオクタノイル基、2−tert−ブチル−2,2,4−トリメチルペンタノイル基、10−メチルドデカノイル基、3−メチルドデカノイル基、4−メチルドデカノイル基、11−メチルドデカノイル基,10−エチルウンデカノイル基、12−メチルトリデカノイル基、2−ブチルデカノイル基、2−ヘキシルオクタノイル基、2−ブチル−2−エチルオクタノイル基、12−メチルテトラデカノイル基、14−メチルペンタデカノイル基、2−ブチルドデカノイル基、2−ヘキシルデカノイル基、16−メチルヘプタデカノイル基、2,2−ジメチルヘキサノイル基、2−ブチルヘキサデカノイル基、2−ヘキシルドデカノイル基、2,4,10,14−テトラメチルペンタノイル基、18−メチルノナデカノイル基、3,7,11,15−テトラ−メチルヘキサデカノイル基、19−メチルエイコサノイル基等を例示することができる。 Further, R 2, R 3, R 5, does not contain a ring structure represented by R 6, R 7, the acyl group of 6 to 22 carbon atoms and having a branch, 2-methyl pentanoyl group, 3-methyl Pentanoyl group, 4-methylpentanoyl group, 2-ethylbutanoyl group, 2-ethylbutanoyl group, 2,2-dimethylbutanoyl group, 3,3-dimethylbutanoyl group, 2-methylhexanoyl group, 4-methylhexanoyl group, 5-methylhexanoyl group, 2,2-dimethylpentanoyl group, 4,4-dimethylpentanoyl group, 2-methylheptanoyl group, 2-ethylhexyl group, 2-propylpentanoyl group 2,2-dimethylhexanoyl group, 2,2,3-trimethylpentanoyl group, 2-methyloctanoyl group, 3,3,5-trimethylhexanoyl group, 2-methylnona Yl group, 4-methylnonanoyl group, 8-methylnonanoyl group, 4-ethyloctanoyl group, 2-ethyloctanoyl group, 2-butylhexanoyl group, 2-tert-butylhexanoyl group, 2,2-diethylhexanoyl group Group, 2,2-dimethyloctanoyl group, 3,7-dimethyloctanoyl group, neodecanoyl group, 7-methyldecanoyl group), 2-methyl-2-ethyloctanoyl group, 2-methylundecanoyl group, 10-methylundecanoyl group, 2,2 dimethyldecanoyl group, 2-ethyldecanoyl group, 2-butyloctanoyl group, diethyloctanoyl group, 2-tert-butyl-2,2,4-trimethylpentanoyl Group, 10-methyldodecanoyl group, 3-methyldodecanoyl group, 4-methyldodecanoyl group, 11-methyldodecanoyl group, 10-ethylundecanoyl group, 12-methyltridecanoyl group, 2-butyldecanoyl group, 2-hexyloctanoyl group, 2-butyl-2-ethyloctanoyl group, 12-methyltetradecanoyl group, 14 -Methylpentadecanoyl group, 2-butyldodecanoyl group, 2-hexyldecanoyl group, 16-methylheptadecanoyl group, 2,2-dimethylhexanoyl group, 2-butylhexadecanoyl group, 2-hexyldodeca Noyl group, 2,4,10,14-tetramethylpentanoyl group, 18-methylnonadecanoyl group, 3,7,11,15-tetra-methylhexadecanoyl group, 19-methyleicosanoyl group, etc. It can be illustrated.
上記一般式(I)又は(II)で表される疎水性モノマーの中でも特に好ましいものとして、下記一般式(IV)又は(V)で表される疎水性モノマーが挙げられる。
一般式(IV)
(一般式(IV)中R11は水素原子または炭素数1〜3のアルキル基を表し、R12,R13は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数10〜22のアシル基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜9のアシル基を表す。Sは三価のアルコールからOH基が脱離した基を表す。)
一般式(V)
(一般式(V)中R14は水素原子または炭素数1〜3のアルキル基を表し、R15,R16,R17は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数10〜22のアシル基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜9のアシル基を表す。Tは四価のアルコールからOH基が脱離した基を表す。)
Among the hydrophobic monomers represented by the general formula (I) or (II), a hydrophobic monomer represented by the following general formula (IV) or (V) is particularly preferable.
Formula (IV)
(In the general formula (IV), R 11 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 12 and R 13 may be the same or different, have no ring structure, and have a branched carbon number. It represents an acyl group having 10 to 22 or a C 6-9 acyl group having two or more branches that does not contain a ring structure, and S represents a group in which an OH group is eliminated from a trivalent alcohol. )
General formula (V)
(In the general formula (V), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 , R 16 , and R 17 may be the same or different and do not include a ring structure and have a branch. Represents an acyl group having 10 to 22 carbon atoms, or an acyl group having 6 to 9 carbon atoms having two or more branches that does not contain a ring structure, and T represents a group in which an OH group is eliminated from a tetravalent alcohol. Represents.)
ここで、R11,R14で表されるアルキル基としては、メチル基、エチル基、プロピル基、イソプロピル基、シクロプロピル基等が例示できる。本発明において、R4,R7は水素原子又はメチル基であることが好ましい。 Here, examples of the alkyl group represented by R 11 and R 14 include a methyl group, an ethyl group, a propyl group, an isopropyl group, and a cyclopropyl group. In the present invention, R 4 and R 7 are preferably a hydrogen atom or a methyl group.
R12、R13、R15、R16、R17で表される、環構造を含まない、分岐を有する炭素数10〜22のアシル基としては、2−メチルノナノイル基、4−メチルノナノイル基、8−メチルノナノイル基、4−エチルオクタノイル基、2−エチルオクタノイル基、2−ブチルヘキサノイル基、2−tert−ブチルヘキサノイル基、2,2−ジエチルヘキサノイル基)、2,2−ジメチルオクタノイル基、3,7−ジメチルオクタノイル基、ネオデカノイル基)、7−メチルデカノイル基、2−メチル−2−エチルオクタノイル基、2−メチルウンデカノイル基、10−メチルウンデカノイル基、2,2ジメチルデカノイル基、2−エチルデカノイル基、2−ブチルオクタノイル基、ジエチルオクタノイル基、2−tert−ブチル−2,2,4−トリメチルペンタノイル基、10−メチルドデカノイル基、3−メチルドデカノイル基、4−メチルドデカノイル基、11−メチルドデカノイル基,10−エチルウンデカノイル基、12−メチルトリデカノイル基、2−ブチルデカノイル基、2−ヘキシルオクタノイル基、2−ブチル−2−エチルオクタノイル基、12−メチルテトラデカノイル基、14−メチルペンタデカノイル基、2−ブチルドデカノイル基、2−ヘキシルデカノイル基、16−メチルヘプタデカノイル基、2,2−ジメチルヘキサノイル基、2−ブチルヘキサデカノイル基、2−ヘキシルドデカノイル基、2,4,10,14−テトラメチルペンタノイル基、18−メチルノナデカノイル基、3,7,11,15−テトラ−メチルヘキサデカノイル基、19−メチルエイコサノイル基等を例示することができる。 Examples of the branched acyl group having 10 to 22 carbon atoms which does not include a ring structure and is represented by R 12 , R 13 , R 15 , R 16 and R 17 include a 2-methylnonanoyl group, a 4-methylnonanoyl group, 8 -Methylnonanoyl group, 4-ethyloctanoyl group, 2-ethyloctanoyl group, 2-butylhexanoyl group, 2-tert-butylhexanoyl group, 2,2-diethylhexanoyl group), 2,2-dimethylocta Noyl group, 3,7-dimethyloctanoyl group, neodecanoyl group), 7-methyldecanoyl group, 2-methyl-2-ethyloctanoyl group, 2-methylundecanoyl group, 10-methylundecanoyl group, 2,2 dimethyldecanoyl group, 2-ethyldecanoyl group, 2-butyloctanoyl group, diethyloctanoyl group, 2-tert-butyl-2,2 4-trimethylpentanoyl group, 10-methyldodecanoyl group, 3-methyldodecanoyl group, 4-methyldodecanoyl group, 11-methyldodecanoyl group, 10-ethylundecanoyl group, 12-methyltridecanoyl group 2-butyldecanoyl group, 2-hexyloctanoyl group, 2-butyl-2-ethyloctanoyl group, 12-methyltetradecanoyl group, 14-methylpentadecanoyl group, 2-butyldodecanoyl group, 2 -Hexyldecanoyl group, 16-methylheptadecanoyl group, 2,2-dimethylhexanoyl group, 2-butylhexadecanoyl group, 2-hexyldecanoyl group, 2,4,10,14-tetramethylpentanoyl Group, 18-methylnonadecanoyl group, 3,7,11,15-tetra-methylhexadecanoyl group, 19-me Examples include a tileicosanoyl group.
また、R12、R13、R15、R16、R17で表される、環構造を含まない、2つ以上の分岐を有する炭素数6〜9のアシル基としては、2,2−ジメチルブタノイル基、3,3−ジメチルブタノイル基、2,2−ジメチルペンタノイル基、4,4−ジメチルペンタノイル基、2,2−ジメチルヘキサノイル基、2,2,3−トリメチルペンタノイル基、3,5,5−トリメチルヘキサノイル基等を例示することができる。 In addition, as the acyl group having 6 to 9 carbon atoms having 2 or more branches and not containing a ring structure, represented by R 12 , R 13 , R 15 , R 16 , R 17 , 2,2-dimethyl Butanoyl group, 3,3-dimethylbutanoyl group, 2,2-dimethylpentanoyl group, 4,4-dimethylpentanoyl group, 2,2-dimethylhexanoyl group, 2,2,3-trimethylpentanoyl group 3,5,5-trimethylhexanoyl group and the like.
P,Sで表される、三価アルコールから誘導される基は、三価アルコールから、OH基が離脱した基であれば特に限定されないが、グリセリン、トリメチロールプロパン、トリメチロールエタンからなる群から選択される三価アルコールから、OH基が離脱した基が好適に例示できる。 The group derived from the trihydric alcohol represented by P and S is not particularly limited as long as the OH group is released from the trihydric alcohol, but from the group consisting of glycerin, trimethylolpropane, and trimethylolethane. A group in which an OH group is eliminated from the selected trihydric alcohol can be suitably exemplified.
また、Q,Tで表される、四価アルコールから誘導される基は、四価アルコールから、OH基が離脱した基であれば特に限定されないが、ジグリセリン、ペンタエリスリトール、エリスリトール、D−トレイトール、L−トレイトールからなる群から選択される四価アルコールから、OH基が離脱した基が好適に例示できる。 The group derived from tetrahydric alcohol represented by Q and T is not particularly limited as long as the OH group is removed from the tetrahydric alcohol, but diglycerin, pentaerythritol, erythritol, D-tray. A group in which an OH group is eliminated from a tetrahydric alcohol selected from the group consisting of Tol and L-Treitol can be preferably exemplified.
本発明のコポリマーにおける、構成単位I及び/又は構成単位IIの全構成単位に占める割合は、好ましくは1〜40質量%、より好ましくは、5〜35質量%である。下限以下では、得られるコポリマーを含有する皮膚外用剤の使用感が低下する場合があり好ましくない。また、上限以上では得られるコポリマーの皮膚外用剤の構成成分、特に水への溶解性が著しく低下し、皮膚外用剤の調製が困難になる場合があり、好ましくない。 The proportion of the structural unit I and / or the structural unit II in the total structural unit in the copolymer of the present invention is preferably 1 to 40% by mass, more preferably 5 to 35% by mass. Below the lower limit, the feeling of use of the external preparation for skin containing the resulting copolymer may be lowered, which is not preferable. On the other hand, if it exceeds the upper limit, the solubility of the copolymer obtained in the external preparation for skin, particularly in water, is markedly lowered, and it may be difficult to prepare the external preparation for skin.
本発明のコポリマーを構成する、一般式(I)で表される疎水性モノマーは例えば、以下の方法で合成することが可能である。
a)三価アルコールをケタール化する。具体的な合成方法としては、例えば、特開2009−136749号公報の製造例1記載の方法が例示できる。
b)aで合成したケタール化された三価アルコールと(メタ)アクリル酸アルキルエステルとのエステル交換でケタールの(メタ)アクリル酸エステルを合成し、得られたケタールの(メタ)アクリル酸エステルの脱ケトン反応を行い、三価アルコールのモノ(メタ)アクリル酸エステルを合成する。具体的な合成方法としては、例えば、特開2004−18389号公報の実施例1記載の方法が例示できる。
c)bで得られた三価アルコールのモノ(メタ)アクリル酸エステルと所定の分岐構造を有するカルボン酸又はその無水物又はそのクロライドとを反応させ、一般式(I)で表される疎水性モノマーを得る。
The hydrophobic monomer represented by the general formula (I) constituting the copolymer of the present invention can be synthesized, for example, by the following method.
a) Ketalize the trihydric alcohol. As a specific synthesis method, for example, the method described in Production Example 1 of JP-A-2009-136749 can be exemplified.
b) A ketal (meth) acrylate ester was synthesized by transesterification of the ketalized trihydric alcohol synthesized in a with a (meth) acrylic acid alkyl ester, and the resulting ketal (meth) acrylic ester was synthesized. Carboxylation reaction is performed to synthesize mono (meth) acrylic acid ester of trihydric alcohol. As a specific synthesis method, for example, the method described in Example 1 of JP-A-2004-18389 can be exemplified.
c) Hydrophobicity represented by the general formula (I) by reacting the mono (meth) acrylic acid ester of the trihydric alcohol obtained in b with a carboxylic acid having a predetermined branched structure or an anhydride or chloride thereof. Monomer is obtained.
なお、ケタール化された三価アルコールには市販品も存在するので、かかる市販品を利用し、上記ステップb)及びc)により本発明の三価アルコールのエステルを得ることも可能である。このような市販品としては、(S)−(+)−2,2−ジメチル−1,3−ジオキサラン−4−メタノール、(R)−(+)−2,2−ジメチル−1,3−ジオキサラン−4−メタノール(いずれも、東京化成工業(株)製)が例示できる。 In addition, since the ketalized trihydric alcohol also has a commercial item, it is also possible to obtain the ester of the trihydric alcohol of the present invention by using the commercially available product and the above steps b) and c). Such commercially available products include (S)-(+)-2,2-dimethyl-1,3-dioxalane-4-methanol, (R)-(+)-2,2-dimethyl-1,3- Examples include dioxalane-4-methanol (both manufactured by Tokyo Chemical Industry Co., Ltd.).
さらに、三価アルコールのモノ(メタ)アクリル酸エステルにも市販品が存在するので、かかる市販品を利用し、上記ステップc)により本発明の三価アルコールのエステルを得ることも可能である。このような市販品としては、「ブレンマーGLM」(グリセリンモノメタクリレート 日本油脂(株)製)が例示できる。 Further, since there are commercially available products of mono (meth) acrylic acid esters of trihydric alcohols, it is also possible to obtain the esters of the trihydric alcohols of the present invention by using the commercially available products and the above step c). An example of such a commercially available product is “Blemmer GLM” (glycerin monomethacrylate manufactured by Nippon Oil & Fats Co., Ltd.).
また、本発明のコポリマーを構成する、一般式(II)で表される疎水性モノマーは、例えば、以下の方法で合成することが可能である。なお、ステップa)及びb)の具体的な方法に関しては、US特許4,405,798、Anne Buyle Padias, H. K. Hall Jr. Macromolecules 15, 217(1982)等に記載されている。
a)四価アルコールの三つのOH基をエステル化しマスキングする。
b)aで合成した化合物と(メタ)アクリル酸又は(メタ)アクリル酸無水物又は(メタ)アクリル酸クロライドを反応させる。得られたエステルをさらに加水分解し、四価アルコールのモノ(メタ)アクリル酸エステルを合成する。
c)bで得られた四価アルコールのモノ(メタ)アクリル酸エステルと所定の分岐構造を有するカルボン酸又はその無水物又はそのクロライドとを反応させ、一般式(II)で表される疎水性モノマーを得る。
Moreover, the hydrophobic monomer represented by the general formula (II) constituting the copolymer of the present invention can be synthesized, for example, by the following method. The specific method of steps a) and b) is described in US Pat. No. 4,405,798, Anne Buyle Padias, HK Hall Jr. Macromolecules 15, 217 (1982) and the like.
a) Esterify and mask the three OH groups of the tetrahydric alcohol.
b) The compound synthesized in a is reacted with (meth) acrylic acid or (meth) acrylic anhydride or (meth) acrylic chloride. The obtained ester is further hydrolyzed to synthesize a mono (meth) acrylic acid ester of a tetrahydric alcohol.
c) Hydrophobic property represented by the general formula (II) by reacting the mono (meth) acrylic acid ester of the tetrahydric alcohol obtained in b with a carboxylic acid having a predetermined branched structure or an anhydride or chloride thereof. Monomer is obtained.
以下、一般式(I)及び(II)で表される疎水性モノマーの製造例を示す。
<製造例1>グリセリンモノアクリレートの合成
3Lの4つ口フラスコに、R)−(+)−2,2−ジメチル−1,3−ジオキサラン−4−メタノール(東京化成工業(株)製)79.5g、メチルアクリレート258.0g、テトラメトキシチタン3.7gを仕込んだ。そして、反応液を撹拌し、液中に窒素ガスを導入しながら、105〜110℃で2.5時間エステル交換反応を行った。反応終了後、減圧蒸留による分取によりケタールアクリレート1(中間体1)を得た。
Hereinafter, production examples of hydrophobic monomers represented by the general formulas (I) and (II) will be shown.
<Production Example 1> Synthesis of glycerin monoacrylate In a 3 L four-necked flask, R)-(+)-2,2-dimethyl-1,3-dioxalane-4-methanol (manufactured by Tokyo Chemical Industry Co., Ltd.) 79 0.5 g, methyl acrylate 258.0 g, and tetramethoxy titanium 3.7 g were charged. Then, the reaction liquid was stirred, and a transesterification reaction was performed at 105 to 110 ° C. for 2.5 hours while introducing nitrogen gas into the liquid. After completion of the reaction, ketal acrylate 1 (intermediate 1) was obtained by fractionation by distillation under reduced pressure.
3L4つ口フラスコに、水90.2g、カチオン交換樹脂RCP160M(三菱化学製)28.4ml、94.2gの中間体1を仕込んだ。そして、反応液を攪拌し、液中に窒素ガスを導入しながら、24℃で27時間ケタールの脱ケトン反応を行った。反応終了後、反応液からカチオン交換樹脂を濾別し、濾別した反応液をヘキサン100mlで6回洗浄して未反応の原料を除いた後、水層に酢酸エチル200mlを加えて生成物を抽出した。そして、この酢酸エチル抽出液を、減圧下(800Pa)、40℃以下で酢酸エチルおよび水を留去し、グリセリルモノアクリレートを得た。 In a 3 L four-necked flask, 90.2 g of water, 28.4 ml of cation exchange resin RCP160M (manufactured by Mitsubishi Chemical), 94.2 g of Intermediate 1 were charged. Then, the reaction solution was stirred, and a ketal deketone reaction was carried out at 24 ° C. for 27 hours while introducing nitrogen gas into the solution. After completion of the reaction, the cation exchange resin was filtered off from the reaction solution, and the filtered reaction solution was washed 6 times with 100 ml of hexane to remove unreacted raw materials, and then 200 ml of ethyl acetate was added to the aqueous layer to obtain a product. Extracted. Then, ethyl acetate and water were distilled off from this ethyl acetate extract under reduced pressure (800 Pa) at 40 ° C. or less to obtain glyceryl monoacrylate.
<製造例2>トリメチロールプロパンモノアクリレートの合成
工程(1):カルシウム管、冷却管及びディーン−スターク(Dean−Stark)トラップを装着したナス型フラスコに、トリメチロールプロパン145.7g、アセトン300ml、p−トルエンスルホン酸1水和物3g及び石油エーテル300mLを加え、50℃に設定したオイルバス中で加熱還流させた。12時間後、新たに水分が生成しなくなったことを確認した後、反応混合物を室温まで冷却した。次いで、酢酸ナトリウム3gを加え、更に30分間攪拌した後、エバポレータにより石油エーテル及びアセトンを留去した。得られた粗生成物を減圧蒸留することにより、ケタール化されたトリメチロールプロパン(中間2)を得た。
<Production Example 2> Synthesis of trimethylolpropane monoacrylate Step (1): 145.7 g of trimethylolpropane, 300 ml of acetone, in an eggplant-shaped flask equipped with a calcium tube, a condenser tube and a Dean-Stark trap. 3 g of p-toluenesulfonic acid monohydrate and 300 mL of petroleum ether were added and heated to reflux in an oil bath set at 50 ° C. After 12 hours, after confirming that water was no longer generated, the reaction mixture was cooled to room temperature. Next, 3 g of sodium acetate was added and the mixture was further stirred for 30 minutes, and then petroleum ether and acetone were distilled off by an evaporator. The obtained crude product was distilled under reduced pressure to obtain ketalized trimethylolpropane (intermediate 2).
工程(2):3Lの4つ口フラスコに、工程(1)で得た中間体2を104.8g、メチルアクリレート258.0g、テトラメトキシチタン3.7gを仕込んだ。そして、反応液を撹拌し、液中に窒素ガスを導入しながら、105〜110℃で2.5時間エステル交換反応を行った。反応終了後、減圧蒸留による分取により、ケタール化されたトリメチロールプロパンのアクリル酸エステル(中間体3)を得た。 Step (2): 104.8 g of Intermediate 2 obtained in Step (1), 258.0 g of methyl acrylate, and 3.7 g of tetramethoxy titanium were charged into a 3 L four-necked flask. Then, the reaction liquid was stirred, and a transesterification reaction was performed at 105 to 110 ° C. for 2.5 hours while introducing nitrogen gas into the liquid. After completion of the reaction, ketalized trimethylolpropane acrylate ester (intermediate 3) was obtained by fractionation by distillation under reduced pressure.
工程(3):3Lの4つ口フラスコに、水90.2g、カチオン交換樹脂RCP160M(三菱化学製)28.4ml、工程(2)で得られた中間体3を115.3g仕込んだ。そして、反応液を攪拌し、液中に窒素ガスを導入しながら、24℃で27時間ケタールの脱ケトン反応を行った。反応終了後、反応液からカチオン交換樹脂を濾別し、濾別した反応液をヘキサン100mlで6回洗浄して未反応の原料を除いた後、水層に酢酸エチル200mlを加えて生成物を抽出した。そして、この酢酸エチル抽出液を、減圧下(800Pa)、40℃以下で酢酸エチルおよび水を留去し、トリメチロールプロパンモノアクリレートを得た。 Step (3): A 3L 4-neck flask was charged with 90.2 g of water, 28.4 ml of cation exchange resin RCP160M (manufactured by Mitsubishi Chemical), and 115.3 g of Intermediate 3 obtained in Step (2). Then, the reaction solution was stirred, and a ketal deketone reaction was carried out at 24 ° C. for 27 hours while introducing nitrogen gas into the solution. After completion of the reaction, the cation exchange resin was filtered off from the reaction solution, and the filtered reaction solution was washed 6 times with 100 ml of hexane to remove unreacted raw materials, and then 200 ml of ethyl acetate was added to the aqueous layer to obtain a product. Extracted. Then, ethyl acetate and water were distilled off from this ethyl acetate extract under reduced pressure (800 Pa) at 40 ° C. or lower to obtain trimethylolpropane monoacrylate.
<製造例3>トリメチロールプロパンモノメタクリレートの合成
製造例2におけるトリメチロールプロパン、メチルアクリレート(アクリレート)、工程(1)で得られる中間体の仕込み量、工程(2)で得られる中間体の仕込み量を表1のように変更した以外は製造例2と同様の操作をおこなって、トリメチロールプロパンモノメタクリレートを合成した。三価のアルコール及びその仕込み量、工程(1)で得られる中間体及びその仕込み量、工程(2)で得られる中間体及びその仕込み量について表1に示す。
<Production Example 3> Synthesis of trimethylolpropane monomethacrylate Trimethylolpropane, methyl acrylate (acrylate) in Production Example 2, the amount of intermediates obtained in step (1), and the intermediates obtained in step (2) Trimethylolpropane monomethacrylate was synthesized in the same manner as in Production Example 2 except that the amount was changed as shown in Table 1. Table 1 shows the trivalent alcohol and its charge, the intermediate obtained in step (1) and its charge, the intermediate obtained in process (2) and its charge.
<製造例4>ペンタエリスリトールモノアクリレートの合成
工程(A)攪拌器、冷却器付3Lの4つ口フラスコに、ペンタエリスリトール34.0g、オルトギ酸トリエチル(シグマ−アルドリッチ社製)37.0g、フタル酸ジオクチル(東京化成工業(株)製)750ml及びパラトルエンスルフォン酸(東京化成工業(株)製)0.1gをとり攪拌混合した。その後、140℃に加熱し、2.5時間反応を行った。反応終了後、減圧蒸留により精製を行って、中間体6を得た。
<Production Example 4> Synthesis of pentaerythritol monoacrylate Step (A) In a 3 L four-necked flask equipped with a stirrer and a condenser, 34.0 g of pentaerythritol, triethyl orthoformate (manufactured by Sigma-Aldrich), 37.0 g, phthalate 750 ml of dioctyl acid (Tokyo Chemical Industry Co., Ltd.) and 0.1 g of paratoluenesulfonic acid (Tokyo Chemical Industry Co., Ltd.) were taken and mixed. Then, it heated at 140 degreeC and reacted for 2.5 hours. After completion of the reaction, purification was performed by distillation under reduced pressure to obtain Intermediate 6.
工程(B)攪拌装置を備えた反応容器中で、工程(A)で得た中間体6を29.2g、トリエチルアミン50.0gをテトラヒドロフラン300mlに溶解した。得られた溶液を氷冷、攪拌しながら、アクリル酸クロライド東京化成工業(株)製)18.1gをテトラヒドロフラン100mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して中間体7を得た。 Step (B) In a reaction vessel equipped with a stirrer, 29.2 g of Intermediate 6 obtained in Step (A) and 50.0 g of triethylamine were dissolved in 300 ml of tetrahydrofuran. While the resulting solution was ice-cooled and stirred, a solution prepared by dissolving 18.1 g of acrylic acid chloride Tokyo Chemical Industry Co., Ltd. in 100 ml of tetrahydrofuran was added dropwise over 2 hours. After completion of the dropwise addition, the produced white precipitate was filtered, and tetrahydrofuran and triethylamine were removed from the filtrate using a rotary evaporator to obtain Intermediate 7.
工程(C)攪拌器、冷却器付の容器中で、40.0gの工程(B)で得た中間体7を水300mlに攪拌溶解した。その後、攪拌を続けながら、70℃で6時間反応を行った後、水を蒸発除去し、乾燥を行って、ペンタエリスリトールモノアクリレートを得た。 Step (C) In a vessel equipped with a stirrer and a cooler, 40.0 g of Intermediate 7 obtained in Step (B) was stirred and dissolved in 300 ml of water. Thereafter, the reaction was carried out at 70 ° C. for 6 hours while continuing the stirring, and then water was removed by evaporation, followed by drying to obtain pentaerythritol monoacrylate.
<製造例5〜7>四価アルコールモノ(メタ)アクリレートの合成
製造例4の工程(A)におけるペンタエリスリトール、工程(B)における工程(A)で得られる中間体の仕込み量及びアクリル酸クロライド、工程(C)における工程(B)で得られる中間体の仕込み量を表2のように変更した以外は製造例4と同様の操作をおこなって、四価アルコールのモノ(メタ)アクリル酸エステルを合成した。四価のアルコール及びその仕込み量、工程(A)で得られる中間体及びその仕込み量、工程(B)で得られる中間体及びその仕込み量、得られるモノ(メタ)アクリル酸エステルについて表2に示す。
<Production Examples 5 to 7> Synthesis of tetrahydric alcohol mono (meth) acrylate Pentaerythritol in the step (A) of Production Example 4, the charge amount of the intermediate obtained in the step (A) in the step (B), and acrylic acid chloride The same operation as in Production Example 4 was carried out except that the amount of the intermediate obtained in step (B) in step (C) was changed as shown in Table 2, and a mono (meth) acrylic acid ester of a tetrahydric alcohol. Was synthesized. Table 2 shows the tetravalent alcohol and its charge, the intermediate obtained in step (A) and its charge, the intermediate obtained in step (B) and its charge, and the resulting mono (meth) acrylate. Show.
* 2)東京化成工業(株)製
<製造例8>一般式(I)で表される疎水性のモノマーの製造例その1
攪拌機及び冷却管を備えた反応容器に、16−メチルヘプタデカン酸(シグマ−アルドリッチ社製)28.4g及び塩化チオニル35.7g(東京化成工業(株)製)、ベンゼン200mlをとり攪拌混合した。攪拌を続けながら、リフラックスを4時間行った後、減圧蒸留による精製を行って、16−メチルヘプタデカン酸クロライドを得た。
<Production Example 8> Production example 1 of a hydrophobic monomer represented by formula (I)
In a reaction vessel equipped with a stirrer and a condenser tube, 28.4 g of 16-methylheptadecanoic acid (manufactured by Sigma-Aldrich), 35.7 g of thionyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) and 200 ml of benzene were stirred and mixed. . While continuing stirring, refluxing was performed for 4 hours, and then purification by vacuum distillation was performed to obtain 16-methylheptadecanoic acid chloride.
攪拌装置を備えた反応容器中で、グリセリルモノメタクリレート(「ブレンマーGLM」日本油脂(株)製)16.0g、トリエチルアミン30.0gをテトラヒドロフラン300mlに溶解した。得られた溶液を氷冷、攪拌しながら、上記で得た16−メチルヘプタデカン酸クロライド60.6gをテトラヒドロフラン100mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(VII)で表される、本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー1)であることが確認された。
一般式(VII)
Formula (VII)
<製造例9>一般式(II)で表される疎水性モノマーの製造例その1
攪拌機及び冷却管を備えた反応容器に、16−メチルヘプタデカン酸(シグマ−アルドリッチ社製)28.4g及び塩化チオニル35.7g(東京化成工業(株)製)、ベンゼン200mlをとり攪拌混合した。攪拌を続けながら、リフラックスを4時間行った後、減圧蒸留による精製を行って、16−メチルヘプタデカン酸クロライドを得た。
<Production Example 9> Production example 1 of a hydrophobic monomer represented by formula (II)
In a reaction vessel equipped with a stirrer and a condenser tube, 28.4 g of 16-methylheptadecanoic acid (manufactured by Sigma-Aldrich), 35.7 g of thionyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) and 200 ml of benzene were stirred and mixed. . While continuing stirring, refluxing was performed for 4 hours, and then purification by vacuum distillation was performed to obtain 16-methylheptadecanoic acid chloride.
攪拌装置を備えた反応容器中で、ペンタエリスリトール(製造例4で得た化合物)19.0g、トリエチルアミン30.0gをテトラヒドロフラン500mlに溶解した。得られた溶液を氷冷、攪拌しながら、上記で得た16−メチルヘプタデカン酸クロライド90.9gをテトラヒドロフラン200mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(VIII)で表される本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー2)であることが確認された。
一般式(VIII)
Formula (VIII)
<製造例10>一般式(I)で表される疎水性のモノマーの製造例その2
攪拌機及び冷却管を備えた反応容器に、19−メチルエイコサン酸(シグマ−アルドリッチ社製)32.7g及び塩化チオニル35.7g(東京化成工業(株)製)、ベンゼン200mlをとり攪拌混合した。攪拌を続けながら、リフラックスを4時間行った後、減圧蒸留による精製を行って、19−メチルエイコサン酸クロライドを得た。
<Production example 10> Production example 2 of a hydrophobic monomer represented by formula (I)
In a reaction vessel equipped with a stirrer and a condenser tube, 32.7 g of 19-methyleicosanoic acid (manufactured by Sigma-Aldrich), 35.7 g of thionyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) and 200 ml of benzene were stirred and mixed. . Refluxing was performed for 4 hours while continuing stirring, and then purification by vacuum distillation was performed to obtain 19-methyleicosanoic acid chloride.
攪拌装置を備えた反応容器中で、トリメチロールエタンモノメタクリレート(製造例3で得られた化合物)18.8g、トリエチルアミン30.0gをテトラヒドロフラン300mlに溶解した。得られた溶液を氷冷、攪拌しながら、上記で得た19−メチルエイコサン酸クロライド69.0gをテトラヒドロフラン100mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(IX)で表される、本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー3)であることが確認された。
一般式(IX)
Formula (IX)
<製造例11>一般式(I)で表される疎水性のモノマーの製造例その3
攪拌機及び冷却管を備えた反応容器に、2,2−ジメチルオクタン酸(シグマ−アルドリッチ社製)17.2g及び塩化チオニル35.7g(東京化成工業(株)製)、ベンゼン200mlをとり攪拌混合した。攪拌を続けながら、リフラックスを4時間行った後、減圧蒸留による精製を行って、2,2−ジメチルオクタン酸クロライドを得た。
<Production Example 11> Production Example 3 of Hydrophobic Monomer Represented by Formula (I) Part 3
In a reaction vessel equipped with a stirrer and a cooling tube, 17.2 g of 2,2-dimethyloctanoic acid (manufactured by Sigma-Aldrich), 35.7 g of thionyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.), and 200 ml of benzene were stirred and mixed. did. While continuing stirring, refluxing was performed for 4 hours, and then purification by vacuum distillation was performed to obtain 2,2-dimethyloctanoic acid chloride.
攪拌装置を備えた反応容器中で、トリメチロールプロパンモノアクリレート(製造例2で得られた化合物)18.8g、トリエチルアミン30.0gをテトラヒドロフラン300mlに溶解した。得られた溶液を氷冷、攪拌しながら、上記で得た2,2−ジメチルオクタン酸クロライド38.2gをテトラヒドロフラン100mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(X)で表される、本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー4)であることが確認された。
一般式(X)
Formula (X)
<製造例12>一般式(I)で表される疎水性のモノマーの製造例その4
攪拌装置を備えた反応容器中で、グリセリルモノアクリレート(製造例1で得た化合物)29.2、トリエチルアミン50.0gをテトラヒドロフラン500mlに溶解した。得られた溶液を氷冷、攪拌しながら、2−エチルヘキサン酸クロライド(シグマ−アルドリッチ社製)65.1gをテトラヒドロフラン100mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(XI)で表される、本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー5)であることが確認された。
一般式(XI)
In a reaction vessel equipped with a stirrer, 29.2 of glyceryl monoacrylate (the compound obtained in Production Example 1) and 50.0 g of triethylamine were dissolved in 500 ml of tetrahydrofuran. While the resulting solution was ice-cooled and stirred, a solution prepared by dissolving 65.1 g of 2-ethylhexanoic acid chloride (manufactured by Sigma-Aldrich) in 100 ml of tetrahydrofuran was added dropwise over 2 hours. After completion of the dropwise addition, the produced white precipitate was filtered, and tetrahydrofuran and triethylamine were removed from the filtrate using a rotary evaporator to obtain a product. By NMR measurement, it was confirmed that the obtained compound was a hydrophobic monomer (hydrophobic monomer 5) derived from the essential structural unit of the copolymer of the present invention represented by the general formula (XI).
Formula (XI)
<製造例13>一般式(II)で表される疎水性モノマーの製造例その2
攪拌装置を備えた反応容器中で、ペンタエリスリトールモノメタクリレート(製造例5で得た化合物)40.8g、トリエチルアミン50.0gをテトラヒドロフラン500mlに溶解した。得られた溶液を氷冷、攪拌しながら、3,5,5−トリメチルヘキサン酸クロライド(シグマ−アルドリッチ社製)106.0gをテトラヒドロフラン200mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(XII)で表される、本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー6)であることが確認された。
一般式(XII)
In a reaction vessel equipped with a stirrer, 40.8 g of pentaerythritol monomethacrylate (the compound obtained in Production Example 5) and 50.0 g of triethylamine were dissolved in 500 ml of tetrahydrofuran. While the resulting solution was ice-cooled and stirred, a solution prepared by dissolving 106.0 g of 3,5,5-trimethylhexanoic acid chloride (manufactured by Sigma-Aldrich) in 200 ml of tetrahydrofuran was added dropwise over 2 hours. After completion of the dropwise addition, the produced white precipitate was filtered, and tetrahydrofuran and triethylamine were removed from the filtrate using a rotary evaporator to obtain a product. From the NMR measurement, it was confirmed that the obtained compound was a hydrophobic monomer (hydrophobic monomer 6) derived from the essential structural unit of the copolymer of the present invention represented by the general formula (XII).
Formula (XII)
<製造例14>一般式(II)で表される疎水性モノマーの製造例その3
攪拌機及び冷却管を備えた反応容器に、2−ブチル−2−エチルオクタン酸(シグマ−アルドリッチ社製)22.8g及び塩化チオニル35.7g(東京化成工業(株)製)、ベンゼン200mlをとり攪拌混合した。攪拌を続けながら、リフラックスを4時間行った後、減圧蒸留による精製を行って、2−ブチル−2−エチルオクタン酸クロライドを得た。
<Production example 14> Production example 3 of a hydrophobic monomer represented by formula (II)
In a reaction vessel equipped with a stirrer and a condenser, 22.8 g of 2-butyl-2-ethyloctanoic acid (manufactured by Sigma-Aldrich), 35.7 g of thionyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.), and 200 ml of benzene are taken. Stir and mix. Refluxing was performed for 4 hours while continuing stirring, and then purification by vacuum distillation was performed to obtain 2-butyl-2-ethyloctanoic acid chloride.
攪拌装置を備えた反応容器中で、ジグリセリンモノアクリレート(製造例6で得た化合物)22.0g、トリエチルアミン30.0gをテトラヒドロフラン300mlに溶解した。得られた溶液を氷冷、攪拌しながら、上記で得た2−ブチル−2−エチルオクタン酸ロライド74.0gをテトラヒドロフラン200mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(XIII)で表される、本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー7)であることが確認された。
一般式(XIII)
Formula (XIII)
<製造例15>一般式(II)で表される疎水性モノマーの製造例その4
攪拌機及び冷却管を備えた反応容器に、19−メチルエイコサン酸(シグマ−アルドリッチ社製)32.7g及び塩化チオニル35.7g(東京化成工業(株)製)、ベンゼン200mlをとり攪拌混合した。攪拌を続けながら、リフラックスを4時間行った後、減圧蒸留による精製を行って、19−メチルエイコサン酸クロライドを得た。
<Production Example 15> Production Example 4 of Hydrophobic Monomer Represented by General Formula (II)
In a reaction vessel equipped with a stirrer and a condenser tube, 32.7 g of 19-methyleicosanoic acid (manufactured by Sigma-Aldrich), 35.7 g of thionyl chloride (manufactured by Tokyo Chemical Industry Co., Ltd.) and 200 ml of benzene were stirred and mixed. . Refluxing was performed for 4 hours while continuing stirring, and then purification by vacuum distillation was performed to obtain 19-methyleicosanoic acid chloride.
攪拌装置を備えた反応容器中で、エリスリトールモノメタクリレート(製造例7で得られた化合物)19.0g、トリエチルアミン50.0gをテトラヒドロフラン300mlに溶解した。得られた溶液を氷冷、攪拌しながら、上記で得た19−メチルエイコサン酸クロライド103.5gをテトラヒドロフラン200mlに溶解してなる溶液を2時間かけて滴下した。滴下終了後、生成した白色沈殿を濾過し、濾液からロータリーエバポレーターを用いてテトラヒドロフラン及びトリエチルアミンを除去して生成物を得た。NMR測定により、得られた化合物が、一般式(XIV)で表される、本発明のコポリマーの必須構成単位を誘導する疎水性モノマー(疎水性モノマー8)であることが確認された。
一般式(XIV)
Formula (XIV)
<2>本発明のコポリマーを構成する親水性モノマーから誘導される構成単位。
本発明のコポリマーは重合性カルボン酸、その塩又は下記一般式(III)で表されるモノマーからなる群から選択される親水性モノマー誘導される構成単位の一種または二種以上を必須構成単位として含有する。(以下、一般式(III)で表されるモノマーからなる群から選択される親水性モノマー誘導される構成単位を単に、構成単位IIIと呼ぶことがある。)
一般式(III)
(一般式(III)中R8は水素原子または炭素数1〜3のアルキル基を表し、R9は水酸基を有していてもよい炭素数2〜4のアルキレン基を表し、R10は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。nは6〜40の整数を表す。)
<2> A structural unit derived from a hydrophilic monomer constituting the copolymer of the present invention.
The copolymer of the present invention has one or more structural units derived from a hydrophilic monomer selected from the group consisting of a polymerizable carboxylic acid, a salt thereof or a monomer represented by the following general formula (III) as essential structural units. contains. (Hereinafter, the structural unit derived from the hydrophilic monomer selected from the group consisting of the monomer represented by the general formula (III) may be simply referred to as the structural unit III.)
Formula (III)
(In the general formula (III), R 8 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 9 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 10 represents hydrogen. An atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, an aliphatic hydrocarbon group having 1 to 14 carbon atoms, or an acyl group having 1 to 12 carbon atoms, and n represents an integer of 6 to 40.)
重合性カルボン酸又はその塩としては、具体的には、アクリル酸、メタクリル酸、クロトン酸、イタコン酸、フマル酸及びそのナトリウム塩、カリウム塩、アンモニウム塩、アミン塩等が例示できる。これらの中では、重合性が高いことから、アクリル酸、メタクリル酸及びその塩が特に好ましい。本発明の水溶性コポリマーに重合性のカルボン酸の塩から誘導される構成単位を導入する場合は重合性カルボン酸を予め塩となし、重合反応を行っても良いし、重合反応により、重合性カルボン酸から誘導される構成単位をコポリマーに誘導した後、塩基により中和して塩となしてもよい。 Specific examples of the polymerizable carboxylic acid or its salt include acrylic acid, methacrylic acid, crotonic acid, itaconic acid, fumaric acid and its sodium salt, potassium salt, ammonium salt, amine salt and the like. Among these, acrylic acid, methacrylic acid and salts thereof are particularly preferable because of high polymerizability. When a structural unit derived from a polymerizable carboxylic acid salt is introduced into the water-soluble copolymer of the present invention, the polymerizable carboxylic acid may be converted into a salt in advance, and a polymerization reaction may be performed. A structural unit derived from a carboxylic acid may be derived into a copolymer and then neutralized with a base to form a salt.
一般式(III)においてR8で表されるアルキル基としては、メチル基、エチル基、プロピル基、1−メチルエチル基、シクロプロピル基が例示できる。本発明において、R8は水素原子又はメチル基であることが好ましい。 Examples of the alkyl group represented by R8 in the general formula (III) include a methyl group, an ethyl group, a propyl group, a 1-methylethyl group, and a cyclopropyl group. In the present invention, R 8 is preferably a hydrogen atom or a methyl group.
また、R9で表されるアルキレン基としては、エチレン基、プロピレン基、イソプロピレン基、2−ヒドロキシプロピレン基、1−ヒドロキシ−2−メチルエチレン基、2−ヒドロキシ−1−メチルエチレン基などが例示できるが、これらのうち、好ましくはエチレン基又はプロピレン基であり、より好ましくはエチレン基である。 Examples of the alkylene group represented by R 9 include an ethylene group, a propylene group, an isopropylene group, a 2-hydroxypropylene group, a 1-hydroxy-2-methylethylene group, and a 2-hydroxy-1-methylethylene group. Of these, ethylene group or propylene group is preferable, and ethylene group is more preferable.
また、R10で表される基のうち、炭素数6〜10の芳香族基としては、フェニル基、ベンジル基、メチルフェニル基、エチルフェニル基等が例示でき;炭素数1〜14の脂肪族炭化水素基としては、メチル基、エチル基、ブチル基、ターシャリーブチル基、ヘキシル基、シクロへキシル基、オクチル基、2−エチルへキシル基、ラウリル基などが好適に例示でき;炭素数1〜12のアシル基としては、フォルミル基、アセチル基、プロピオニル基、ブチリル基、イソブチリル基、バレリル基、ラウロイル基などが好適に例示できる。これらのうち、R5で表される基として好ましくは炭素数1〜14の脂肪族炭化水素基であり、より好ましくは炭素数1〜12のアルキル基である。 In addition, among the groups represented by R 10 , examples of the aromatic group having 6 to 10 carbon atoms include a phenyl group, a benzyl group, a methylphenyl group, and an ethylphenyl group; an aliphatic group having 1 to 14 carbon atoms Preferred examples of the hydrocarbon group include a methyl group, an ethyl group, a butyl group, a tertiary butyl group, a hexyl group, a cyclohexyl group, an octyl group, a 2-ethylhexyl group, and a lauryl group; Preferable examples of the ˜12 acyl group include a formyl group, an acetyl group, a propionyl group, a butyryl group, an isobutyryl group, a valeryl group, and a lauroyl group. Among these, the group represented by R 5 is preferably an aliphatic hydrocarbon group having 1 to 14 carbon atoms, and more preferably an alkyl group having 1 to 12 carbon atoms.
さらに、一般式(III)におけるnは6〜40の数値範囲であることが重要である。本発明においてnが上記範囲である構成単位IIをコポリマーに導入することにより、皮膚外用剤の構成成分、特に水への溶解性が良好であるコポリマーを得て、容易にコポリマーを皮膚外用剤に含有させることが可能となり、かつ、皮膚外用剤に優れた保湿効果及び使用感を付与することができる。nが6未満の場合は得られるコポリマーの皮膚外用剤の構成成分、特に水への溶解性が著しく低下する場合があり、好ましくない。反対に、nが40より大きすぎると皮膚外用剤のべたつきやきしみが増幅される場合があるので好ましくない。 Furthermore, it is important that n in the general formula (III) is in a numerical range of 6 to 40. In the present invention, by introducing the structural unit II in which n is in the above range into the copolymer, a component of the external preparation for skin, particularly a copolymer having good solubility in water, can be obtained, and the copolymer can be easily used as an external preparation for skin. It can be contained, and an excellent skin moisturizing effect and feeling of use can be imparted to the external preparation for skin. When n is less than 6, the solubility of the resulting copolymer in the external preparation for skin, particularly water, may be significantly lowered, which is not preferable. On the other hand, if n is larger than 40, the stickiness and squeak of the external preparation for skin may be amplified, which is not preferable.
上記一般式(III)で表されるモノマーのうち、R9がプロピレン基であるモノマーとして具体的には、ポリプロピレングリコール(9)モノアクリレート、ポリプロピレングリコール(13)モノアクリレート、ポリプロピレングリコール(9)モノメタクリレート、ポリプロピレングリコール(13)モノメタクリレート等が挙げられる。なお、括弧内の数字はnを表す。これらのポリマーの多くは市販品として入手可能である。これら市販品としては、具体的には、商品名「ブレンマー」AP−400、AP−550、AP−800、PP−500、PP−800(いずれも日本油脂(株)製)等が例示できる。なお、R4がエチレン基であるモノマーの具体例は後述する。 Among the monomers represented by the general formula (III), specific examples of the monomer in which R 9 is a propylene group include polypropylene glycol (9) monoacrylate, polypropylene glycol (13) monoacrylate, and polypropylene glycol (9) mono Examples include methacrylate and polypropylene glycol (13) monomethacrylate. The number in parentheses represents n. Many of these polymers are commercially available. Specific examples of these commercially available products include “Blemmer” AP-400, AP-550, AP-800, PP-500, PP-800 (all manufactured by NOF Corporation) and the like. A specific example of the monomer in which R 4 is an ethylene group will be described later.
上記一般式(III)で表される親水性モノマーから誘導される構成単位の中でも特に好ましいものとして、下記一般式(VI)で表される親水性モノマーから誘導される構成単位が挙げられる。
一般式(VI)
(一般式(VI)中R18は水素原子または炭素数1〜3のアルキル基を表し、R19は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。mは6〜40の整数を表す。)
Among the structural units derived from the hydrophilic monomer represented by the general formula (III), a structural unit derived from the hydrophilic monomer represented by the following general formula (VI) is particularly preferable.
Formula (VI)
(In General Formula (VI), R 18 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 19 represents a hydrogen atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, or an aliphatic group having 1 to 14 carbon atoms. A hydrocarbon group or a C1-C12 acyl group is represented.m represents an integer of 6-40.)
このような一般式(III)で表されるモノマーを具体的に例示すれば、ポリエチレングリコール(10)モノアクリレート、ポリエチレングリコール(8)モノメタクリレート、ポリエチレングリコール(23)モノアクリレート、ポリエチレングリコール(23)モノメタクリレート、メトキシポリエチレングリコール(9)アクリレート、メトキシポリエチレングリコール(9)メタクリレート、メトキシポリエチレングリコール(23)メタクリレート、オレイロキシポリエチレングリコール(18)メタクリレート、ラウロキシポリエチレングリコール(18)アクリレート、ラウロイロキシポリエチレングリコール(10)メタクリレート、ステアロキシポリエチレングリコール(30)モノメタクリレート等が挙げられる。なお、括弧内の数字はmの値を示す。 Specific examples of the monomer represented by the general formula (III) include polyethylene glycol (10) monoacrylate, polyethylene glycol (8) monomethacrylate, polyethylene glycol (23) monoacrylate, and polyethylene glycol (23). Monomethacrylate, methoxypolyethylene glycol (9) acrylate, methoxypolyethylene glycol (9) methacrylate, methoxypolyethylene glycol (23) methacrylate, oleyloxypolyethylene glycol (18) methacrylate, lauroxypolyethylene glycol (18) acrylate, lauryloxypolyethylene glycol (10) Methacrylate, stearoxy polyethylene glycol (30) monomethacrylate and the like. The number in parentheses indicates the value of m.
なお、一般式(III)において述べたように、一般式(VI)においても同様に、膚外用剤の構成成分、特に水への溶解性が良好であるコポリマーを得て、かつ、皮膚外用剤に優れた保湿効果及び使用感を付与ためにはmは6〜40の数値範囲であることが重要である。 In addition, as described in the general formula (III), similarly in the general formula (VI), a component having a good solubility in water, particularly a component for external preparation of the skin, and a skin external preparation are obtained. It is important that m is in the numerical range of 6 to 40 in order to impart an excellent moisturizing effect and usability.
これら上記の親水性モノマーは、対応するポリエチレングリコール、ポリエチレングリコールモノエーテル、ポリエチレングリコールモノエステルとアクリル酸又はメタクリル酸のクロライド又は無水物とのエステル化反応により高収率で得ることができる。また、既に市販品も多数存在するので、かかる市販品を利用することも可能である。このような市販品としては、具体的に、商品名ブレンマー、AE−400、PE−350、AME−400、PME−400、PME−1000、ALE−800、PSE−1300等(いずれも日本油脂(株)製)等が例示できる。 These hydrophilic monomers can be obtained in high yield by an esterification reaction of the corresponding polyethylene glycol, polyethylene glycol monoether, polyethylene glycol monoester and acrylic acid or methacrylic acid chloride or anhydride. Moreover, since there are already many commercial products, it is also possible to use such commercial products. Specific examples of such commercially available products include the trade names Blemmer, AE-400, PE-350, AME-400, PME-400, PME-1000, ALE-800, PSE-1300, etc. Etc.).
本発明のコポリマーに含まれる親水性のモノマーから誘導される構成単位は1種のみでもよいが、前述の条件を満たすものであれば2種以上の構成単位を組み合わせて含有していてもよい。 The structural unit derived from the hydrophilic monomer contained in the copolymer of the present invention may be only one type, but may contain two or more types of structural units in combination as long as the above-mentioned conditions are satisfied.
本発明のコポリマーにおける、親水性のモノマーから誘導される構成単位の全構成単位に占める割合は、好ましくは30〜95質量%、より好ましくは、40〜90質量%である。下限以下では、得られるコポリマーの膚外用剤の構成成分、特に水への溶解性が著しく低下する場合があり、好ましくない。また、上限以上では得られるコポリマーを含有する皮膚外用剤のべたつきやきしみが増幅される場合があり好ましくない。 In the copolymer of the present invention, the proportion of the structural units derived from the hydrophilic monomer to the total structural units is preferably 30 to 95% by mass, more preferably 40 to 90% by mass. Below the lower limit, the solubility of the obtained copolymer in the external preparation for skin, particularly water, may be significantly lowered, which is not preferable. On the other hand, if it exceeds the upper limit, the stickiness and squeakiness of the external preparation containing the copolymer obtained may be amplified, which is not preferable.
<3>本発明のコポリマーに含まれうるその他の任意の構成単位
本発明のコポリマーは、上記の構成単位I及び構成単位IIから選択される一種又は二種以上の必須構成単位、親水性モノマーから誘導される必須構成単位以外に、通常共重合体で使用されるモノマーから誘導される単位を、発明の効果を損なわない範囲で任意の構成単位として含有することができる。かかる任意の構成単位としては、アクリル酸アミド、メタクリル酸アミド、アクリル酸モノアルキルアミド、メタクリル酸モノアルキルアミド等の(メタ)アクリル酸アミド、(メタ)アクリル酸メチル、(メタ)アクリル酸エチル、(メタ)アクリル酸−n−ブチル、(メタ)アクリル酸イソブチル、(メタ)アクリル酸−tert−ブチル、(メタ)アクリル酸n−オクチル、(メタ)アクリル酸−2エチルヘキシル、メタクリル酸n−ドデシル、(メタ)アクリル酸ステアリル、(メタ)アクリル酸イソステアリル等(メタ)アクリル酸アルキルエステル、(メタ)アクリル酸シクロヘキシル等の(メタ)アクリル酸の環状アルキルエステ、ル2−ヒドロキシエチル(メタ)アクリレート、2−ヒドロキシプロピル(メタ)アクリレート、4−ヒドロキシブチル(メタ)アクリレート等の(メタ)アクリル酸ヒドロキシアルキルエステル、(メタ)アクリル酸ベンジル等の(メタ)アクリル酸アリールエステル、(メタ)アクリル酸メトキシメチル、(メタ)アクリル酸メトキシエチル等の(メタ)アクリル酸アルコキシアルキルエステル、酢酸ビニル、ビニルピロリドン、スチレン、α−メチルスチレン、アクリロニトリル等のモノマーから誘導される構造単位が例示できる。これらのモノマーの殆どは市販品として入手可能である。
<3> Other optional structural units that can be included in the copolymer of the present invention The copolymer of the present invention is composed of one or more essential structural units selected from the structural unit I and the structural unit II, and a hydrophilic monomer. In addition to the essential structural unit derived, a unit derived from a monomer usually used in a copolymer can be contained as an arbitrary structural unit within a range not impairing the effects of the invention. Examples of such optional structural units include acrylic acid amide, methacrylic acid amide, acrylic acid monoalkylamide, (meth) acrylic acid amide such as methacrylic acid monoalkylamide, methyl (meth) acrylate, ethyl (meth) acrylate, (Meth) acrylic acid-n-butyl, (meth) acrylic acid isobutyl, (meth) acrylic acid-tert-butyl, (meth) acrylic acid n-octyl, (meth) acrylic acid-2-ethylhexyl, methacrylate n-dodecyl methacrylate (Meth) acrylic acid stearyl, (meth) acrylic acid isostearyl (meth) acrylic acid alkyl ester, (meth) acrylic acid cyclic alkyl ester such as cyclohexyl (meth) acrylic acid, 2-hydroxyethyl (meth) Acrylate, 2-hydroxypropyl (meth) acrylate, 4 -(Meth) acrylic acid hydroxyalkyl esters such as hydroxybutyl (meth) acrylate, (meth) acrylic acid aryl esters such as benzyl (meth) acrylate, methoxymethyl (meth) acrylate, methoxyethyl (meth) acrylate, etc. Examples thereof include structural units derived from monomers such as (meth) acrylic acid alkoxyalkyl esters, vinyl acetate, vinylpyrrolidone, styrene, α-methylstyrene, acrylonitrile and the like. Most of these monomers are commercially available.
<4>本発明のコポリマー
本発明のコポリマーは、上記構成単位I及び/又は構成単位II及び親水性のモノマーから誘導される必須構成単位、並びに必要に応じて任意の構成単位を、その骨格中に含有する共重合体である。
<4> Copolymer of the Present Invention The copolymer of the present invention comprises an essential structural unit derived from the structural unit I and / or the structural unit II and a hydrophilic monomer, and an optional structural unit as necessary in its skeleton. Is a copolymer contained in
また、本発明のコポリマーは通常はその構成単位がランダムに結合したランダム共重合体であるが、ブロック共重合体又はグラフト共重合体であってもよい。 Further, the copolymer of the present invention is usually a random copolymer in which structural units are randomly bonded, but may be a block copolymer or a graft copolymer.
本発明のコポリマーの製造方法は特に限定されないが、例えば各構成単位を誘導するモノマーを溶媒中で混合し、アクリル系モノマーの重合で通常用いられる方法に従って重合反応を行う方法により得ることができる。 The method for producing the copolymer of the present invention is not particularly limited. For example, the copolymer can be obtained by a method in which monomers for deriving each structural unit are mixed in a solvent and a polymerization reaction is carried out according to a method usually used in the polymerization of acrylic monomers.
また、本発明のコポリマーは、皮膚外用剤への配合が容易であることから、水溶性であることが好ましい。ここでいう水溶性コポリマーとは25℃において、コポリマーの20質量%水溶液の透過率が90%以上あるコポリマーと定義される。このようなポリマーを得るためには、上記重合方法の中でも前記モノマー混合物を、水溶液と25℃で水と任意の割合で混和する水性溶媒との混合溶媒中で、ラジカル重合する重合方法が特に好ましい。また、重合反応後の残存モノマーの量が少ないことから、水の替わりに緩衝溶液を用いる重合法がさらに好ましい。この方法で使用する緩衝作用を有する水溶液としては、通常使用される緩衝溶液であれば特に限定されないが、具体的には、塩化カリウム−塩酸溶液、フタル酸水素カリウム−塩酸溶液、リン酸二水素カリウム−リン酸水素二ナトリウム溶液、クエン酸水素カリウム−クエン酸溶液、炭酸ナトリウム−炭酸水素ナトリウム溶液等が例示できる。また、開始剤のイオンと緩衝溶液を形成するような塩類、酸或いは塩基類の水溶液を用い、開始剤を添加した時点で緩衝溶液をとなしてもよい。さらに、この方法で用いる25℃で水と任意の割合で混和する水性溶媒としては、具体的にはメチルアルコール、エチルアルコール、n−プロピルアルコール、イソプロピルアルコール等の炭素数1〜3のアルコール、アセトン、メチルエチルケトン等のケトン、エチレングリコール、ポリエチレングリコール、プロピレングリコール、1,3ブチレングリコール等のジオール、エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル等のエチレングリコールモノアルキルエーテル、テトラヒドロフラン等が例示できる。これらの水性溶媒の中では、重合反応が進行しやすいことから、メチルアルコール、エチルアルコール、n−プロピルアルコール、イソプロピルアルコール等の炭素数1〜3のアルコールが特に好ましい。 The copolymer of the present invention is preferably water-soluble because it can be easily blended into a skin external preparation. The water-soluble copolymer here is defined as a copolymer having a transmittance of 90% or more of a 20% by mass aqueous solution of the copolymer at 25 ° C. In order to obtain such a polymer, among the above polymerization methods, a polymerization method in which the monomer mixture is radically polymerized in a mixed solvent of an aqueous solution and an aqueous solvent mixed with water at an arbitrary ratio at 25 ° C. is particularly preferable. . Moreover, since the amount of residual monomer after the polymerization reaction is small, a polymerization method using a buffer solution instead of water is more preferable. The aqueous solution having a buffering action used in this method is not particularly limited as long as it is a commonly used buffer solution. Specifically, potassium chloride-hydrochloric acid solution, potassium hydrogen phthalate-hydrochloric acid solution, dihydrogen phosphate Examples thereof include potassium-disodium hydrogen phosphate solution, potassium hydrogen citrate-citric acid solution, and sodium carbonate-sodium hydrogen carbonate solution. Alternatively, an aqueous solution of salts, acids, or bases that forms a buffer solution with the ions of the initiator may be used to form a buffer solution when the initiator is added. Furthermore, as an aqueous solvent mixed with water at an arbitrary ratio at 25 ° C. used in this method, specifically, alcohols having 1 to 3 carbon atoms such as methyl alcohol, ethyl alcohol, n-propyl alcohol and isopropyl alcohol, acetone Examples thereof include ketones such as methyl ethyl ketone, diols such as ethylene glycol, polyethylene glycol, propylene glycol and 1,3 butylene glycol, ethylene glycol monoalkyl ethers such as ethylene glycol monomethyl ether and ethylene glycol monoethyl ether, and tetrahydrofuran. Among these aqueous solvents, alcohols having 1 to 3 carbon atoms such as methyl alcohol, ethyl alcohol, n-propyl alcohol, and isopropyl alcohol are particularly preferable because the polymerization reaction easily proceeds.
以下本発明のコポリマーの製造例を示す。
<製造例16>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、疎水性モノマー1(製造例8)30.0g、メトキシポリエチレングリコール(23)メタクリレート(日本油脂(株)製、商品名「ブレンマーPME−1000」)90.0g、イソプロピルアルコール300ml、りん酸塩緩衝溶液(pH6.8)(ナカライテスク(株)製)300mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、本発明のコポリマー1の水溶液を得た。
Hereinafter, production examples of the copolymer of the present invention will be shown.
<Production Example 16>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 30.0 g of hydrophobic monomer 1 (Production Example 8), methoxypolyethylene glycol (23) methacrylate (manufactured by NOF Corporation, trade name “Blemmer PME-1000” ] 90.0 g, isopropyl alcohol 300 ml, phosphate buffer solution (pH 6.8) (manufactured by Nacalai Tesque Co., Ltd.) 300 ml were taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 1 of the present invention.
<製造例17>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、疎水性モノマー2(製造例9)18.0g、メトキシポリエチレングリコール(23)メタクリレート(日本油脂(株)製、商品名「ブレンマーPME−1000」)90.0g、2−ヒドロキシエチルメタクリレート(東京化成工業(株)製)12.0g、イソプロピルアルコール300ml、りん酸塩緩衝溶液(pH6.8)(ナカライテスク(株)製)300mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、60℃で18時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、本発明のコポリマー2の水溶液を得た。
<Production Example 17>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 18.0 g of hydrophobic monomer 2 (Production Example 9), methoxypolyethylene glycol (23) methacrylate (manufactured by NOF Corporation, trade name “Blemmer PME-1000” ] 90.0 g, 2-hydroxyethyl methacrylate (Tokyo Kasei Kogyo Co., Ltd.) 12.0 g, isopropyl alcohol 300 ml, phosphate buffer solution (pH 6.8) (Nacalai Tesque Co., Ltd.) 300 ml and stirred Mixed. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was performed at 60 ° C. for 18 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 2 of the present invention.
<製造例18>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに疎水性モノマー5(製造例12)36.0g、アクリル酸(東京化成工業(株)製)84.0g、エチルアルコール300mlと0.05M炭酸ナトリウム水溶液30ml及び0.1M炭酸水素ナトリウム溶液270mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、60℃で20時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでエチルアルコールを除去し、本発明のコポリマー3の水溶液を得た。
<Production Example 18>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 36.0 g of hydrophobic monomer 5 (Production Example 12), 84.0 g of acrylic acid (manufactured by Tokyo Chemical Industry Co., Ltd.), 300 ml of ethyl alcohol and 0.05 M carbonic acid 30 ml of an aqueous sodium solution and 270 ml of a 0.1 M sodium bicarbonate solution were taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution obtained by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was further performed at 60 ° C. for 20 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and ethyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 3 of the present invention.
<製造例19>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、疎水性モノマー4(製造例11)24.0g、メトキシポリエチレングリコール(9)メタクリレート(日本油脂(株)製、商品名「ブレンマーPME−400」)72.0g、2−ヒドロキシエチルメタクリレート(東京化成工業(株)製)24.0g、イソプロピルアルコール300ml、0.2M塩化カリウム水溶液75ml、0.2N塩酸15.8ml及び水209.2mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、70℃で14時間反応を行った。反応終了後、水酸化カリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、本発明のコポリマー4の水溶液を得た。
<Production Example 19>
In a flask equipped with a nitrogen introduction tube, a condenser and a stirrer, 24.0 g of hydrophobic monomer 4 (Production Example 11), methoxypolyethylene glycol (9) methacrylate (manufactured by NOF Corporation, trade name “Blemmer PME-400” 72.0 g, 2-hydroxyethyl methacrylate (Tokyo Kasei Kogyo Co., Ltd.) 24.0 g, isopropyl alcohol 300 ml, 0.2 M aqueous potassium chloride solution 75 ml, 0.2N hydrochloric acid 15.8 ml and water 209.2 ml. Stir and mix. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was performed at 70 ° C. for 14 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous potassium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 4 of the present invention.
<製造例20>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、疎水性モノマー3(製造例10)9.0g、ポリエチレングリコール(10)モノアクリレート(日本油脂(株)製、商品名「ブレンマーAE−400」)45.0g、メチルメタクリレート(東京化成工業(株)製)6.0g、エチレングリコールモノメチルエーテル180ml及び0.002N塩酸120mを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム1.0gを水10mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化カリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでエチレングリコールモノメチルエーテルを除去し、本発明のコポリマー5の水溶液を得た。
<Production Example 20>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 9.0 g of hydrophobic monomer 3 (Production Example 10), polyethylene glycol (10) monoacrylate (manufactured by NOF Corporation, trade name “Blemmer AE-400” ] 45.0 g, 6.0 g of methyl methacrylate (manufactured by Tokyo Chemical Industry Co., Ltd.), 180 ml of ethylene glycol monomethyl ether and 120 m of 0.002N hydrochloric acid were mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 1.0 g of ammonium persulfate in 10 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous potassium hydroxide solution, and ethylene glycol monomethyl ether was removed with a rotary evaporator to obtain an aqueous solution of copolymer 5 of the present invention.
<製造例21>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、疎水性モノマー6(製造例13)24.0g、メトキシポリエチレングリコール(9)アクリレート(日本油脂(株)製、商品名「ブレンマーAME−400」)90.0g、2−ヒドロキシエチルアクリレート(東京化成工業(株)製)6.0g、イソプロピルアルコール300ml、りん酸塩緩衝溶液(pH6.8)(ナカライテスク(株)製)300mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、65℃で16時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでイソプロピルアルコールを除去し、本発明の水溶性コポリマー6の水溶液を得た。
<Production Example 21>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 24.0 g of hydrophobic monomer 6 (Production Example 13), methoxypolyethylene glycol (9) acrylate (manufactured by NOF Corporation, trade name “Blemmer AME-400” ] 90.0 g, 2-hydroxyethyl acrylate (Tokyo Kasei Kogyo Co., Ltd.) 6.0 g, isopropyl alcohol 300 ml, phosphate buffer solution (pH 6.8) (Nacalai Tesque Co., Ltd.) 300 ml and stirred. Mixed. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution prepared by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was continued at 65 ° C. for 16 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and isopropyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of the water-soluble copolymer 6 of the present invention.
<製造例22>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに疎水性モノマー8(製造例15)12.0g、アクリル酸(東京化成工業(株)製)100.8g、エチルアルコール300mlと0.05M炭酸ナトリウム水溶液30ml及び0.1M炭酸水素ナトリウム溶液270mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過硫酸アンモニウム2.0gを水20mlに溶解した溶液を加え、更に攪拌を続けながら、60℃で20時間反応を行った。反応終了後、水酸化ナトリウム水溶液を用いてpHを7.0に調整し、ロータリーエバポレーターでエチルアルコールを除去し、本発明のコポリマー7の水溶液を得た。
<Production Example 22>
12.0 g of hydrophobic monomer 8 (Production Example 15), 100.8 g of acrylic acid (manufactured by Tokyo Chemical Industry Co., Ltd.), 300 ml of ethyl alcohol and 0.05 M carbonic acid in a flask equipped with a nitrogen inlet tube, a condenser and a stirrer 30 ml of an aqueous sodium solution and 270 ml of a 0.1 M sodium bicarbonate solution were taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution obtained by dissolving 2.0 g of ammonium persulfate in 20 ml of water was added thereto, and the reaction was further performed at 60 ° C. for 20 hours while continuing stirring. After completion of the reaction, the pH was adjusted to 7.0 using an aqueous sodium hydroxide solution, and ethyl alcohol was removed using a rotary evaporator to obtain an aqueous solution of copolymer 7 of the present invention.
<製造例23>
窒素導入管、冷却器及び攪拌装置を備えたフラスコに、疎水性モノマー7(製造例14)15.0g、ポリエチレングリコール(9)モノメタクリレート(日本油脂(株)製、商品名「ブレンマーPE−400」)45.0g、酢酸エチル180ml及びエチルアルコール120mlを採り攪拌混合した。攪拌を続けながら、1時間窒素ガス置換を行った。これに過酸化ベンゾイル0.5gをエチルアルコール10mlに溶解した溶液を加え、更に攪拌を続けながら、8時間、リフラックスを行った。反応終了後、水300mlを添加し、ロータリーエバポレーターで酢酸エチル及びエチルアルコールを除去し、本発明のコポリマー8の水溶液を得た。
<Production Example 23>
In a flask equipped with a nitrogen inlet tube, a condenser and a stirrer, 15.0 g of hydrophobic monomer 7 (Production Example 14), polyethylene glycol (9) monomethacrylate (manufactured by NOF Corporation, trade name “Blemmer PE-400” ] 45.0 g, 180 ml of ethyl acetate and 120 ml of ethyl alcohol were taken and mixed with stirring. While stirring was continued, nitrogen gas substitution was performed for 1 hour. A solution obtained by dissolving 0.5 g of benzoyl peroxide in 10 ml of ethyl alcohol was added thereto, and reflux was performed for 8 hours while continuing stirring. After completion of the reaction, 300 ml of water was added, and ethyl acetate and ethyl alcohol were removed by a rotary evaporator to obtain an aqueous solution of copolymer 8 of the present invention.
<製造例24>
特開2002−193730号公報の製造例1に記載の方法と同様の操作をおこなってコポリマー9を得た。
<Production Example 24>
A copolymer 9 was obtained in the same manner as in the method described in Production Example 1 of JP-A-2002-193730.
<製造例25>
特開2004−123726号公報の製造例12に記載の方法と同様の操作をおこなってコポリマー10の水溶液を得た。
<Production Example 25>
An aqueous solution of copolymer 10 was obtained in the same manner as described in Production Example 12 of JP-A No. 2004-123726.
<4>本発明の皮膚外用剤
本発明の皮膚外用剤は、上記構成単位I及び/又は構成単位II及び親水性のモノマーから誘導される構成単位、並びに必要に応じて任意の構成単位を、その骨格中に含有するコポリマーを必須成分として含有する。
<4> External preparation for skin of the present invention The external preparation for skin of the present invention comprises a structural unit derived from the structural unit I and / or the structural unit II and a hydrophilic monomer, and if necessary, an arbitrary structural unit. The copolymer contained in the skeleton is contained as an essential component.
本発明の皮膚外用剤における、該コポリマーの含有量は、好ましくは、0.5〜30質量%、さらに好ましくは、1〜25質量%である。下限値以下では本発明の効果が発揮されない場合があり好ましくない。また、上限値以上では、皮膚外用剤構成成分、特に水への溶解性が低く、コポリマーを均一に含有する皮膚外用剤の調製が困難である場合があり好ましくない。 The content of the copolymer in the external preparation for skin of the present invention is preferably 0.5 to 30% by mass, more preferably 1 to 25% by mass. Below the lower limit, the effect of the present invention may not be exhibited, which is not preferable. On the other hand, when the amount is not less than the upper limit value, it is not preferable because the preparation for the external preparation for skin, particularly the solubility in water, is low, and the preparation of the external preparation for skin containing the copolymer uniformly may be difficult.
本発明の皮膚外用剤としては、軟膏等の外用医薬品、化粧品等が好適に例示できる。さらに、化粧品としては、クリーム、乳液、化粧水、美容液等のスキンケア、アンダーメーク、ファンデーション、アイカラー、マスカラ等のメークアップ、へアトニック、ヘアリキッド、ヘアスプレー等の毛髪化粧料等が例示できる。 As an external preparation for skin of the present invention, external medicines such as ointments, cosmetics and the like can be suitably exemplified. Furthermore, examples of cosmetics include skin care such as cream, milky lotion, skin lotion, and beauty serum, make-up such as under makeup, foundation, eye color, mascara, and hair cosmetics such as hair tonic, hair liquid, and hair spray. .
本発明の皮膚外用剤は発明の効果を損なわない範囲で、通常、皮膚外用剤に使用する、成分を、任意成分として含有することができる。かかる任意成分としては、具体的に、
マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類、流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類、脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類、塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類、ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類、ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキシレングリコール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸,ローカストビーンガム,サクシノグルカン,カロニン酸,キチン,キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレングリコール、ベントナイト等の増粘剤、エタノール、イソプロパノール等の低級アルコール類、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル及、t−ブチルメトキシベンゾイルメタン、パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤等の紫外線吸収剤、ビタミンA又はその誘導体、ビタミンB6塩酸塩,ビタミンB6トリパルミテート,ビタミンB6ジオクタノエート,ビタミンB2又はその誘導体,ビタミンB12,ビタミンB15又はその誘導体等のビタミンB類、α−トコフェロール,β−トコフェロール,γ−トコフェロール,ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類などが好ましく例示できる。
The external preparation for skin of the present invention can contain, as an optional component, components that are usually used for external preparations for skin as long as the effects of the invention are not impaired. As such optional components, specifically,
Macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil, hydrogenated oil, molasses, hydrogenated castor oil, Oils such as beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum, hydrocarbons such as microcrystalline wax, Higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, Higher alcohols such as cutyldecanol, myristyl alcohol, cetostearyl alcohol, etc., cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, diisostearyl malate, Di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, triisostearic acid trimethylol Synthetic ester oils such as propane, tetra-2-ethylhexanoic acid pentane erythritol, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane Linear polysiloxanes such as, cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc. Oils such as silicone oils such as modified polysiloxanes, fatty acid soaps (sodium laurate, sodium palmitate, etc.), anionic surfactants such as potassium lauryl sulfate, alkylethanol triethanolamine ether, stearyltrimethylammonium chloride, chloride Cationic surfactants such as benzalkonium and laurylamine oxide, imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide-1-cal Boxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyltaurine, sorbitan fatty acid esters (sorbitan monostearate, sorbitan sesquioleate, etc.) ), Glycerin fatty acids (such as glyceryl monostearate), propylene glycol fatty acid esters (such as propylene glycol monostearate), hydrogenated castor oil derivatives, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene monostearate) Sorbitan, etc.), POE sorbite fatty acid esters (POE-sorbite monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerol monoisostearate, etc.), POE fat Acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl ether, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), nonionic surfactants such as sucrose fatty acid ester, alkyl glucoside Polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene Moisturizing composition of polyalcohols such as coal, 1,2-pentanediol, 2,4-hexylene glycol, 1,2-hexanediol, 1,2-octanediol, sodium pyrrolidonecarboxylate, lactic acid, sodium lactate Classification, guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluron Acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran , Keratosulfuric acid, locust bean gum, succinoglucan, caronic acid, chitin, chitosan, carboxymethyl chitin, agar, polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, sodium polyacrylate, polyethylene glycol, bentonite and other thickeners, Lower alcohols such as ethanol and isopropanol, hexyl diethylaminohydroxybenzoylbenzoate, t-butylmethoxybenzoylmethane, paraaminobenzoic acid UV absorber, anthranilic acid UV absorber, salicylic acid UV absorber, cinnamic acid UV absorber UV absorbers, vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives, vitamin B12, vitamin B15 such as vitamin B15 or derivatives thereof, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone, etc. Of these, vitamins can be preferably exemplified.
本発明の皮膚外用剤は、上記必須成分と任意成分とを常法によって処理することにより、調製ずることができる。 The skin external preparation of this invention can be prepared by processing the said essential component and an arbitrary component by a conventional method.
以下、実施例を挙げて本発明を具体的に説明するが、本発明がこれら実施例にのみ限定されないことは言うまでもない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated concretely, it cannot be overemphasized that this invention is not limited only to these Examples.
<実施例1〜3、比較例1〜3>
下記の表3に示す処方に従って、本発明の皮膚外用剤である化粧水及び比較例の化粧水を作製した。即ち、表1に示す成分(イ)の混合物を室温で攪拌混合し均一溶液とした。成分(ロ)の混合物を75℃に加熱し、攪拌混合し均一溶液とした。成分(イ)の混合物を攪拌しながら、室温まで冷却した成分(ロ)の混合物をゆっくり添加し、二つの溶液を混合して化粧水を得た。なお、表3中の数字は質量%を表す。
<Examples 1-3, Comparative Examples 1-3>
According to the formulation shown in Table 3 below, skin lotions that are external preparations for skin of the present invention and skin lotions for comparative examples were prepared. That is, the mixture of component (a) shown in Table 1 was stirred and mixed at room temperature to obtain a uniform solution. The mixture of the component (b) was heated to 75 ° C. and stirred to obtain a uniform solution. While stirring the mixture of component (a), the mixture of component (b) cooled to room temperature was slowly added, and the two solutions were mixed to obtain a lotion. The numbers in Table 3 represent mass%.
<試験例1>皮膚の保湿性試験
試験は、5名のパネラーを対象として、20℃、相対湿度50%の部屋で実施した。測定部位を37℃の温水で30秒間洗浄し、20分間安静にし、その後、測定を行った。前腕内側部の皮膚を対象として、試験予定日の前日(−1日)に試験予定部位の皮膚水分量をSKICON−200EX(IBS社製)にて測定した。その後、5%濃度のラウリル硫酸ナトリウム水溶液を含浸させたガーゼ(2cm×2cm)を30分間接触させた。翌日(0日)SKICON−200EXにて、皮膚水分量を測定、その後、実施例1〜3の化粧水及び比較例1〜3の化粧水を塗布した。試験サンプルの塗布は、一日3回実施した。塗布1日後、2日後に再度皮膚水分量を測定した。同時に、試験サンプルの塗布を行わない未処置対照の試験も実施した。なお、測定値は5名のパネラーの平均値とした。結果を表4に示す。
Test Example 1 Skin Moisturizing Test The test was conducted in a room at 20 ° C. and 50% relative humidity for five panelists. The measurement site was washed with warm water at 37 ° C. for 30 seconds, allowed to rest for 20 minutes, and then measured. For the skin on the inner side of the forearm, the skin moisture content at the planned test site was measured with SKICON-200EX (IBS) on the day before the test scheduled date (-1 day). Thereafter, gauze (2 cm × 2 cm) impregnated with a 5% sodium lauryl sulfate aqueous solution was contacted for 30 minutes. The skin moisture content was measured on the next day (day 0) SKICON-200EX, and then the lotions of Examples 1 to 3 and the lotions of Comparative Examples 1 to 3 were applied. The test sample was applied three times a day. The skin moisture content was measured again 1 day and 2 days after application. At the same time, an untreated control test in which no test sample was applied was also performed. In addition, the measured value was made into the average value of five panelists. The results are shown in Table 4.
<試験例2>粘着性の測定スライドガラス上に実施例1〜3の化粧水及び比較例1〜3の化粧水0.1mlを1.2cmφの面積に塗布し、化粧水の使用中の状態を意識し、40℃、相対湿度60%で一時間乾燥し、試験膜を作成した。この試験膜の粘着性をハンディー圧着試験器KES−G5((株)カトーテック製)を用いて評価した。粘着性は装置のヘッドを塗布膜から引き剥がす際の粘着力(g)で表した。すなわち、この値が高いほど塗布膜の粘着性が高いことを表している。結果を表4に示す。 <Test Example 2> Measurement of adhesiveness The cosmetic lotions of Examples 1 to 3 and 0.1 ml of the cosmetics of Comparative Examples 1 to 3 were applied to an area of 1.2 cmφ on the slide glass, and the cosmetic solution was in use. , And dried at 40 ° C. and a relative humidity of 60% for 1 hour to prepare a test film. The adhesion of this test film was evaluated using a handy pressure tester KES-G5 (manufactured by Kato Tech Co., Ltd.). The adhesiveness was expressed as an adhesive force (g) when the head of the apparatus was peeled off from the coating film. That is, the higher this value, the higher the adhesiveness of the coating film. The results are shown in Table 4.
<試験例3>動摩擦係数の測定
人肌類似のポリウレタン製合成皮革(試験前に予めエタノールで表面を清潔にしておく)の短冊(15cm×5cm)上の長手方向の端から1cmで、3cm×3cmの範囲に、実施例1〜3の化粧水及び比較例1〜3の化粧水20mgを均一に塗布し、両面テープで実験台に固定する。一方、同じ合成皮革片3cm×3cmを、荷重を載せる治具に両面テープで貼り付けておく。前記試料の塗布面に、上記治具を合成皮革の面を対向させて載置し、荷重200gを載せ、表面性試験機(トリラボ ハンディーラブテスター Type TL701)にて摩擦抵抗を測定した。測定条件は、掃引速度200mm/sec、掃引距離10cm、リピート回数10回とし、往路の10回の摩擦抵抗値の平均を動摩擦抵抗値とした。動摩擦係数は、動摩擦抵抗値÷荷重にて算出した。動摩擦係数が小さいほど、滑りに対する抵抗が無いことを表す。結果を表4に示す。
<Test Example 3> Measurement of dynamic friction coefficient 1 cm from the longitudinal end of a strip (15 cm × 5 cm) of a synthetic leather made of polyurethane similar to human skin (previously cleaned with ethanol before the test), 3 cm × 3 cm × In the range of 3 cm, the skin lotions of Examples 1 to 3 and the skin lotions of Comparative Examples 1 to 3 are uniformly applied and fixed to the experimental table with double-sided tape. On the other hand, the same synthetic leather piece 3 cm × 3 cm is attached to a jig for placing a load with double-sided tape. The jig was placed on the coated surface of the sample so that the surface of the synthetic leather faced, a load of 200 g was placed, and the frictional resistance was measured with a surface property tester (Trilab Handy Love Tester Type TL701). The measurement conditions were a sweep speed of 200 mm / sec, a sweep distance of 10 cm, a repeat count of 10 times, and the average of the 10 frictional resistance values in the forward path was defined as the dynamic frictional resistance value. The dynamic friction coefficient was calculated by dynamic friction resistance value / load. A smaller dynamic friction coefficient indicates that there is no resistance to slipping. The results are shown in Table 4.
<試験例4>べたつき及びきしみの評価
熟練評価者5名により、肌上に塗布中の実施例1〜3の化粧水及び比較例1〜3の化粧水のべたつき及びきしみを以下の評価基準で官能評価した。
べたつき 1:べたつきをかなり感じる、2:べたつきを感じる、3:べたつきをやや感じる、4:べたつきをごくわずかに感じる、5:べたつきを全く感じない。
きしみ 1:きしみをかなり感じる、2:きしみを感じる、3:きしみをやや感じる、4:きしみをごくわずかに感じる、5:きしみを全く感じない。
なお、評価は比較例1の化粧水の評点を3.0としておこない、5名の評点の平均値をサンプルの評点とした。結果を表4に示す。
<Test example 4> Evaluation of stickiness and squeak The stickiness and squeak of the lotions of Examples 1 to 3 and Comparative Examples 1 to 3 being applied on the skin by five skilled evaluators according to the following evaluation criteria. Sensory evaluation was performed.
Stickiness 1: Feels stickiness considerably 2: Feels stickiness 3: Feels stickiness slightly 4: Feels stickiness very slightly 5: Does not feel stickiness at all
Squeak 1: Feels squeak fairly 2: Feels squeak 3: Feels squeak slightly 4: Feels squeak slightly 5: Does not feel squeak at all
In addition, evaluation was performed by setting the skin lotion of Comparative Example 1 to 3.0, and the average value of the scores of 5 people was used as the sample score. The results are shown in Table 4.
<実施例4〜6、比較例4〜6>
下記の表5に示す処方に従って、本発明の皮膚外用剤である乳液と比較例の乳液を作製した。即ち、表5に示す成分(イ)の混合物および成分(ロ)の混合物を80℃に加熱し、攪拌混合して、それぞれ均一溶液とした。温度を80℃に保ちながら、攪拌を行いつつ、成分(イ)の混合物に(ロ)の混合物を徐々に加えて乳化し、攪拌冷却して乳液を得た。なお、表5中の数字は質量%を表す。実施例4〜6、比較例4〜6で得た乳液を用いて、試験例1〜4と同様の方法で皮膚の保湿性、粘着性、動摩擦係数、べたつき、きしみを評価した。べたつきときしみの評価に於いては比較例4の評点を3.0とした。結果を表6に示す。
<Examples 4-6, Comparative Examples 4-6>
According to the formulation shown in Table 5 below, an emulsion which is an external preparation for skin of the present invention and an emulsion of a comparative example were prepared. That is, the mixture of component (A) and the mixture of component (B) shown in Table 5 were heated to 80 ° C. and mixed by stirring to obtain uniform solutions. While maintaining the temperature at 80 ° C., while stirring, the mixture of (b) was gradually added to the mixture of component (a) to emulsify, and stirred to cool to obtain an emulsion. The numbers in Table 5 represent mass%. Using the emulsions obtained in Examples 4 to 6 and Comparative Examples 4 to 6, skin moisture retention, adhesiveness, dynamic friction coefficient, stickiness, and squeak were evaluated in the same manner as in Test Examples 1 to 4. In the evaluation of stickiness and blotch, the score of Comparative Example 4 was set to 3.0. The results are shown in Table 6.
<実施例7〜9、比較例7〜9>
下記の表7に示す処方に従って、本発明の皮膚外用剤であるクリームと比較例のクリームを作製した。即ち、表7に示す成分(イ)の混合物に、成分(ロ)を分散させた。分散された成分(ロ)を含む成分(イ)の混合物を攪拌しながら80℃に加熱し、これに80℃に加熱された成分(ハ)の混合物を徐々に加えて乳化させた。得られた乳化物を攪拌冷却して、クリームを得た。なお、表7中の数字は質量%を表す。実施例7〜9、比較例7〜9で得たクリームを用いて、試験例1〜4と同様の方法で皮膚の保湿性、粘着性、動摩擦係数、べたつき、きしみを評価した。べたつきときしみの評価に於いては比較例7の評点を3.0とした。結果を表8に示す。
<Examples 7-9, Comparative Examples 7-9>
According to the formulation shown in Table 7 below, a cream which is a skin external preparation of the present invention and a cream of a comparative example were prepared. That is, the component (b) was dispersed in the mixture of the component (a) shown in Table 7. The mixture of component (a) containing dispersed component (b) was heated to 80 ° C. while stirring, and the mixture of component (c) heated to 80 ° C. was gradually added to emulsify. The obtained emulsion was stirred and cooled to obtain a cream. The numbers in Table 7 represent mass%. Using the creams obtained in Examples 7 to 9 and Comparative Examples 7 to 9, skin moisture retention, adhesiveness, coefficient of dynamic friction, stickiness, and squeak were evaluated in the same manner as in Test Examples 1 to 4. In the evaluation of stickiness and stains, the score of Comparative Example 7 was set to 3.0. The results are shown in Table 8.
<実施例10〜12、比較例10〜12>
下記の表9に示す処方に従って、本発明の皮膚外用剤であるファンデーションと比較例のファンデーションを作製した。即ち、表9に示す成分(イ)の混合物および成分(ロ)の混合物を80℃に加熱し、攪拌混合して、それぞれ均一溶液とした。成分(イの混合物に(ハ)を加えて、ディスパーを用いて分散し、温度を80℃に保ちながら、攪拌を行いつつ、成分(ロ)の混合物を徐々に加えて乳化し、攪拌冷却してファンデーションを得た。なお、表9中の数字は質量%を表す。実施例10〜12、比較例10〜12で得たファンデーションを用いて、試験例1〜4と同様の方法で皮膚の保湿性、粘着性、動摩擦係数、べたつき、きしみを評価した。べたつきときしみの評価に於いては比較例10の評点を3.0とした。結果を表10に示す。
<Examples 10-12, Comparative Examples 10-12>
According to the formulation shown in Table 9 below, a foundation which is an external preparation for skin of the present invention and a foundation for a comparative example were prepared. That is, the mixture of the component (I) and the mixture of the component (B) shown in Table 9 were heated to 80 ° C. and mixed by stirring to obtain uniform solutions. Add (c) to component (a), disperse using disper, and while stirring at temperature of 80 ° C., gradually add component (b) to emulsify, stir and cool. In addition, the numbers in Table 9 represent mass%, and using the foundations obtained in Examples 10 to 12 and Comparative Examples 10 to 12, the same method as in Test Examples 1 to 4 was used. Moisturizing property, adhesiveness, coefficient of dynamic friction, stickiness, and creaking were evaluated, and in the evaluation of stickiness and creaking, the score of Comparative Example 10 was set to 3.0, and the results are shown in Table 10.
本発明は化粧料に活用できる。
The present invention can be used for cosmetics.
Claims (7)
一般式(I)
(一般式(I)中R1は水素原子または炭素数1〜3のアルキル基を表し、R2,R3は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数6〜22のアシル基を表す。Pは三価のアルコールからOH基が脱離した基を表す。)
一般式(II)
(一般式(II)中R4は水素原子または炭素数1〜3のアルキル基を表し、R5,R6,R7は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数6〜22のアシル基を表す。Qは四価のアルコールからOH基が脱離した基を表す。)
A群:重合性カルボン酸、下記一般式(III)で表される親水性モノマー
一般式(III)
(一般式(III)中R8は水素原子または炭素数1〜3のアルキル基を表し、R9は水酸基を有していてもよい炭素数2〜4のアルキレン基を表し、R10は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。nは6〜40の整数を表す。) One or more structural units derived from a hydrophobic monomer represented by the following general formula (I) or (II) and one or more structural units derived from a hydrophilic monomer consisting of the following group A As an essential constituent unit, and the proportion of one or two or more constituent units derived from the hydrophobic monomer to the total constituent units is 1 to 40% by mass, and one or more constituent units derived from the hydrophilic monomer The skin external preparation characterized by containing the copolymer which the ratio to the total structural unit of 2 or more types of structural units is 30-95 mass%, and may have another structural unit.
Formula (I)
(In the general formula (I), R 1 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 2 and R 3 may be the same or different, have no ring structure and have a branched carbon number. Represents an acyl group of 6 to 22. P represents a group in which an OH group is eliminated from a trivalent alcohol.
Formula (II)
(In the general formula (II), R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 5 , R 6 and R 7 may be the same or different and do not contain a ring structure and have a branch. Represents an acyl group having 6 to 22 carbon atoms, Q represents a group in which an OH group is eliminated from a tetravalent alcohol.
Group A: polymerizable carboxylic acid, hydrophilic monomer represented by the following general formula (III) general formula (III)
(In the general formula (III), R 8 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 9 represents an alkylene group having 2 to 4 carbon atoms which may have a hydroxyl group, and R 10 represents hydrogen. An atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, an aliphatic hydrocarbon group having 1 to 14 carbon atoms, or an acyl group having 1 to 12 carbon atoms, and n represents an integer of 6 to 40.)
一般式(IV)
(一般式(IV)中R11は水素原子または炭素数1〜3のアルキル基を表し、R12,R13は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数10〜22のアシル基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜9のアシル基を表す。Sは三価のアルコールからOH基が脱離した基を表す。)
一般式(V)
(一般式(V)中R14は水素原子または炭素数1〜3のアルキル基を表し、R15,R16,R17は同一でも異なっていてもよく、環構造を含まない、分岐を有する、炭素数10〜22のアシル基、または、環構造を含まない、2つ以上の分岐を有する炭素数6〜9のアシル基を表す。Tは四価のアルコールからOH基が脱離した基を表す。) The hydrophobic monomer represented by the general formula (I) is a hydrophobic monomer represented by the following general formula (IV), and the hydrophobic monomer represented by the general formula (II) is represented by the following general formula (V) The external preparation for skin according to claim 1, which is a hydrophobic monomer represented by the formula:
Formula (IV)
(In the general formula (IV), R 11 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 12 and R 13 may be the same or different, have no ring structure, and have a branched carbon number. It represents an acyl group having 10 to 22 or a C 6-9 acyl group having two or more branches that does not contain a ring structure, and S represents a group in which an OH group is eliminated from a trivalent alcohol. )
General formula (V)
(In the general formula (V), R 14 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 15 , R 16 , and R 17 may be the same or different and do not include a ring structure and have a branch. Represents an acyl group having 10 to 22 carbon atoms, or an acyl group having 6 to 9 carbon atoms having two or more branches that does not contain a ring structure, and T represents a group in which an OH group is eliminated from a tetravalent alcohol. Represents.)
一般式(VI)
(一般式(VI)中R18は水素原子または炭素数1〜3のアルキル基を表し、R19は水素原子、炭素数6〜10の芳香族炭化水素基、炭素数1〜14の脂肪族炭化水素基又は炭素数1〜12のアシル基を表す。mは6〜40の整数を表す。) The skin external preparation according to claim 1 or 2, wherein the hydrophilic monomer represented by the general formula (III) is a hydrophilic monomer represented by the following general formula (VI).
Formula (VI)
(In the general formula (VI), R 18 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R 19 represents a hydrogen atom, an aromatic hydrocarbon group having 6 to 10 carbon atoms, or an aliphatic group having 1 to 14 carbon atoms. A hydrocarbon group or a C1-C12 acyl group is represented.m represents an integer of 6-40.)
It is a cosmetic, The skin external preparation of any one of Claims 1-6 characterized by the above-mentioned.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016114582A JP6199443B2 (en) | 2016-06-08 | 2016-06-08 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016114582A JP6199443B2 (en) | 2016-06-08 | 2016-06-08 | Topical skin preparation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012146191A Division JP6144466B2 (en) | 2012-06-29 | 2012-06-29 | Topical skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016155876A JP2016155876A (en) | 2016-09-01 |
JP6199443B2 true JP6199443B2 (en) | 2017-09-20 |
Family
ID=56824975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016114582A Active JP6199443B2 (en) | 2016-06-08 | 2016-06-08 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6199443B2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005325060A (en) * | 2004-05-14 | 2005-11-24 | Pola Chem Ind Inc | Skin care preparation for external use |
JP5348877B2 (en) * | 2007-12-10 | 2013-11-20 | 花王株式会社 | Oil-in-water emulsified cosmetic |
JP6144465B2 (en) * | 2012-06-29 | 2017-06-07 | ポーラ化成工業株式会社 | Topical skin preparation |
JP5944244B2 (en) * | 2012-06-29 | 2016-07-05 | ポーラ化成工業株式会社 | New copolymer |
-
2016
- 2016-06-08 JP JP2016114582A patent/JP6199443B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016155876A (en) | 2016-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6144466B2 (en) | Topical skin preparation | |
JP6144465B2 (en) | Topical skin preparation | |
JP5978059B2 (en) | Skin preparation | |
AU671062B2 (en) | Use of a salicylic acid derivative as a stabilizer for an oil-in-water emulsion | |
JP2019131492A (en) | Skin external preparations or cosmetics | |
JP2011195510A (en) | Oil-in-water type emulsified skin external composition | |
JP5972098B2 (en) | Skin preparation | |
JP2007269723A (en) | Cosmetic | |
JP6199443B2 (en) | Topical skin preparation | |
US20220023183A1 (en) | Composition comprising a polysaccharide, a polyol and a specific ester | |
JP5851725B2 (en) | Water-based or oil-in-water emulsified makeup cosmetics | |
JP4332062B2 (en) | Water-in-oil whitening cosmetic | |
KR102431188B1 (en) | External skin preparation for wrinkle improvement | |
JP6608612B2 (en) | Copolymer | |
JP5978058B2 (en) | Skin preparation | |
JP6758877B2 (en) | O / W type emulsified composition | |
JP2008013450A (en) | Oil in water type emulsifier type cosmetic | |
TWI690541B (en) | Copolymer | |
JP2010090155A (en) | Emulsified cosmetic | |
JP7100744B2 (en) | Emulsifying composition | |
JP2020200255A (en) | Skin cosmetic | |
JP6189709B2 (en) | Itching inhibitor | |
JP4963873B2 (en) | Oil-in-water emulsion composition | |
JP2006257188A (en) | Dispersion of aqueous polymer composition | |
JP2016210919A (en) | Coated film having sea-island structure and composition forming the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160608 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170620 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170616 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170809 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170822 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170823 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6199443 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |